e10vqza
Table of Contents

 
 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q/A


     
þ   QUARTERLY REPORT PURSUANT SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2005
or

     
o   TRANSITION REPORT PURSUANT SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-29472

AMKOR TECHNOLOGY, INC.

(Exact name of registrant as specified in its charter)
     
Delaware
(State of incorporation)
  23-1722724
(I.R.S. Employer Identification Number)

1900 South Price Road
Chandler, AZ 85248
(480) 821-5000
(Address of principal executive offices and zip code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been subject to filing requirements for the past 90 days. Yes þ No o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes þ No o

The number of outstanding shares of the registrant’s Common Stock as of June 1, 2005 was 176,714,357.

 
 

 


EXPLANATORY NOTE

     We are filing this amendment on Form 10-Q/A to our Quarterly Report on Form 10-Q to restate our condensed consolidated financial statements for the three months ended March 31, 2005. In connection with finalizing the restatement of our previously filed financial statements for each of the three years in the period ended December 31, 2004, as included in our amended Annual Report on Form 10-K/A filed on June 6, 2005, we have revised the amount of unpaid capital expenditures utilized in preparing our condensed consolidated statement of cash flows for the three months ended March 31, 2005 that was included in our Quarterly Report on Form 10-Q filed on May 16, 2005. In conjunction with the restatement of our Annual Report, as described above, we restated our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, and September 30 of 2004. We filed amendments on Form 10-Q/A to these Quarterly Reports on June 6, 2005.

     No attempt has been made in this Form 10-Q/A to update other disclosures presented in the original report on Form 10-Q, except as required to reflect the effects of the restatement. This Form 10-Q/A does not reflect events occurring after the filing of the original Form 10-Q or modify or update those disclosures, including the exhibits to the Form 10-Q affected by subsequent events; however, this Form 10-Q/A includes as exhibits 31.1, 31.2 and 32 new certifications by our principal executive officer and principal financial officer as required by Rule 12b-15 promulgated under the Securities Exchange Act of 1934, as amended. Accordingly, this Form 10-Q/A should be read in conjunction with our filings made with the SEC subsequent to the filing of the original Form 10-Q, including any amendments to those filings. The following items have been amended as a result of the restatement:

     Part I — Item 1 — Financial Statements

     Part I — Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations

     Part I — Item 4 — Controls and Procedures

QUARTERLY REPORT ON FORM 10-Q
March 31, 2005

TABLE OF CONTENTS

             
        Page  
        No.  
 
  PART I. Financial Information        
  Financial Statements (unaudited)     3  
  Management’s Discussion and Analysis of Financial Condition and Results of Operations     24  
  Quantitative and Qualitative Disclosures About Market Risk     30  
  Controls and Procedures     31  
 
           
 
  PART II. Other Information        
  Legal Proceedings     32  
  Unregistered Sales of Equity Securities and Use of Proceeds     36  
  Defaults Upon Senior Securities     36  
  Submission of Matters to a Vote of Security Holders     36  
  Other Information     36  
  Exhibits     37  
 
  Signatures        
 Exhibit 12.1
 Exhibit 31.1
 Exhibit 31.2
 Exhibit 32

 


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

AMKOR TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(unaudited)

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
 
               
Net sales
  $ 417,481     $ 464,646  
Cost of sales
    374,086       352,798  
 
           
Gross profit
    43,395       111,848  
 
           
Operating expenses:
               
Selling, general and administrative
    58,492       52,178  
Research and development
    8,900       8,977  
Amortization of intangibles
    1,974       1,328  
Provision for legal settlements and contingencies (Note 12)
    50,000       1,500  
 
           
Total operating expenses
    119,366       63,983  
 
           
Operating income (loss)
    (75,971 )     47,865  
 
           
Other expense (income):
               
Interest expense, net
    40,513       33,290  
Foreign currency exchange loss
    2,232       75  
Other expense (income), net
    178       (923 )
Debt retirement expense
          2,720  
 
           
Total other expense (income)
    42,923       35,162  
 
           
Income (loss) before income taxes and minority interest
    (118,894 )     12,703  
Minority interest
    1,011       (358 )
 
           
Income (loss) before income taxes
    (117,883 )     12,345  
Provision for income taxes
    1,187       1,435  
 
           
Net income (loss)
  $ (119,070 )   $ 10,910  
 
           
 
               
Per share data:
               
Basic and diluted net income (loss) per common share
  $ (0.68 )   $ 0.06  
 
           
 
               
Shares used in computing basic income (loss) per common share
    175,718       174,622  
 
           
 
               
Shares used in computing diluted income (loss) per common share
    175,718       180,202  
 
           

The accompanying notes are an integral part of these statements.

3


Table of Contents

AMKOR TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(unaudited)

                 
    March 31,     December 31,  
    2005     2004  
 
               
Assets
Current assets:
               
Cash and cash equivalents
  $ 286,760     $ 372,284  
Accounts receivable:
               
Trade, net of allowance of $5,115 in 2005 and $5,074 in 2004
    265,137       265,547  
Other
    5,912       3,948  
Inventories, net (Note 3)
    111,638       111,616  
Other current assets
    33,348       32,591  
 
           
Total current assets
    702,795       785,986  
 
               
Property, plant and equipment, net (Note 4)
    1,372,149       1,380,396  
Goodwill (Note 5)
    655,858       656,052  
Intangibles, net (Note 5)
    44,918       47,302  
Investments (Note 6)
    11,646       13,762  
Other assets
    78,971       81,870  
 
           
Total assets
  $ 2,866,337     $ 2,965,368  
 
           
 
               
Liabilities and Stockholders’ Equity
 
               
Current liabilities:
               
Bank overdraft
  $       $ 102  
Short-term borrowings and current portion of long-term debt (Note 9)
    42,245       52,147  
Trade accounts payable
    201,577       211,706  
Accrued expenses (Note 7)
    209,666       175,075  
 
           
Total current liabilities
    453,488       439,030  
 
               
Long-term debt (Note 9)
    2,042,411       2,040,813  
Other non-current liabilities
    117,663       109,317  
 
           
Total liabilities
    2,613,562       2,589,160  
 
           
 
               
Commitments and contingencies (Note 12)
               
 
               
Minority interest
    5,807       6,679  
 
           
 
               
Stockholders’ equity:
               
Preferred stock, $0.001 par value, 10,000 shares authorized designated Series A, none issued
               
Common stock, $0.001 par value, 500,000 shares authorized issued and outstanding of 175,718 in 2005 and 175,718 in 2004
    176       176  
Additional paid-in capital
    1,323,579       1,323,579  
Accumulated deficit
    (1,088,142 )     (969,072 )
Accumulated other comprehensive income
    11,355       14,846  
 
           
Total stockholders’ equity
    246,968       369,529  
 
           
Total liabilities and stockholders’ equity
  $ 2,866,337     $ 2,965,368  
 
           

The accompanying notes are an integral part of these statements.

4


Table of Contents

AMKOR TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(unaudited)

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (restated)          
Cash flows from operating activities:
               
Net income (loss)
  $ (119,070 )   $ 10,910  
Depreciation and amortization
    60,858       52,397  
Other non-cash items
    1,382       5,262  
Changes in assets and liabilities excluding effects of acquisitions
    50,388       28,769  
 
           
Net cash (used in) provided by operating activities
    (6,442 )     97,338  
 
           
 
               
Cash flows from investing activities:
               
Payments for property, plant and equipment
    (66,712 )     (143,851 )
Acquisition, net of cash acquired
          (12,858 )
Proceeds from the sale of property, plant and equipment
    156       685  
Proceeds from note receivable
          18,627  
 
           
Net cash used in investing activities
    (66,556 )     (137,397 )
 
           
 
               
Cash flows from financing activities:
               
Net change in bank overdrafts
    (102 )     (2,155 )
Borrowings under the revolving credit facility
    55,603       65,646  
Payments under the revolving credit facility
    (63,813 )     (71,041 )
Proceeds from issuance of long-term debt
          252,159  
Payments for debt issuance costs
          (3,152 )
Payments of long-term debt, including redemption premium payment in 2004
    (3,504 )     (171,551 )
Proceeds from issuance of stock through stock compensation plans
          1,846  
 
           
Net cash (used in) provided by financing activities
    (11,816 )     71,752  
 
           
 
               
Effect of exchange rate fluctuations on cash and cash equivalents
    (710 )     544  
 
           
 
               
Net change in cash and cash equivalents
    (85,524 )     32,237  
Cash and cash equivalents, beginning of period
    372,284       313,259  
 
           
Cash and cash equivalents, end of period
  $ 286,760     $ 345,496  
 
           
 
               
Supplemental disclosures of cash flow information:
               
Cash paid during the period for:
               
Interest
  $ 40,170     $ 27,519  
Income taxes
  $ 2,733     $ 11,781  

The accompanying notes are an integral part of these statements.

5


Table of Contents

AMKOR TECHNOLOGY, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1. Interim Financial Statements

     Basis of Presentation. The condensed consolidated financial statements and related disclosures as of March 31, 2005 and for the three months ended March 31, 2005 and 2004 are unaudited, pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In our opinion, these financial statements include all adjustments (consisting only of normal recurring adjustments) necessary for the fair statement of the results for the interim periods. These financial statements should be read in conjunction with our latest Annual Report as of December 31, 2004 filed on Form 10-K/A with the Securities and Exchange Commission.

     The results of operations for the three months ended March 31, 2005 are not necessarily indicative of the results to be expected for the full year. Certain previously reported amounts have been reclassified to conform to the current period presentation.

     2005 restatement. We are filing this amendment on Form 10-Q/A to our Quarterly Report on Form 10-Q to restate our condensed consolidated financial statements for the three months ended March 31, 2005. In connection with finalizing the restatement of our previously filed financial statements for each of the three years in the period ended December 31, 2004, as included in our amended Annual Report on Form 10-K/A filed on June 6, 2005, we have revised the amount of unpaid capital expenditures utilized in preparing our condensed consolidated statement of cash flows for the three months ended March 31, 2005 that was included in our Quarterly Report on Form 10-Q filed on May 16, 2005. In conjunction with the restatement of our Annual Report, as described above, we restated our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, and September 30 of 2004. We filed amendments on Form 10-Q/A to these Quarterly Reports on June 6, 2005.

     The following table sets forth the effects of the restatement on certain line items within our previously reported condensed consolidated statement of cash flows for the three months ended March 31, 2005:

                         
    As                
    Previously             As  
    Reported     Adjustments     Restated  
    (In thousands)  
 
                       
Changes in assets and liabilities excluding effects of acquisitions
  $ 48,962     $ 1,426     $ 50,388  
Net cash used in operating activities
    (7,868 )     1,426       (6,442 )
Payments for property, plant and equipment
    (65,286 )     (1,426 )     (66,712 )
Net cash used in investing activities
    (65,130 )     (1,426 )     (66,556 )

     Use of Estimates. The condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S.”), using management’s best estimates and judgments where appropriate. These estimates and judgments affect the reported amounts of assets and liabilities and disclosure of the contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ materially from these estimates and judgments.

     Income Taxes. For the three months ended March 31, 2005, income tax expense was $1.2 million, reflecting an effective tax rate of 1.0%. For the three months ended March 31, 2004, income tax expense was $1.4 million, reflecting an effective tax rate of 11.3%. Our effective tax rates for the three months ended March 31, 2005 and March 31, 2004 differ significantly from the U.S. statutory tax rate of 35% primarily due to tax losses in the U.S. and certain foreign jurisdictions for which we can not take a benefit. The tax expense for the three months ended March 31, 2005 and March 31, 2004 related primarily to foreign withholding taxes and income taxes at our profitable foreign locations.

     We operate in and file income tax returns in various U.S. and foreign jurisdictions which are subject to examination by tax authorities. For our larger operations, our tax returns have been examined through 1998 in the Philippines and the U.S., through 2000 in Taiwan, and through 2002 in Japan. The tax returns for open years in all jurisdictions in which we do business are subject to changes upon examination. During 2003, the Internal Revenue Service commenced an examination

6


Table of Contents

related to years 2000 and 2001. In February 2005, we verbally agreed to a settlement in principle with the IRS for these years. As a component of the settlement, we agreed to make certain income adjustments to our U.S. tax returns in the years 2000 through 2003 for local attribution of income resulting from significant inter-company transactions, including ownership and use of intellectual property, in various U.S. and foreign jurisdictions. These adjustments would effectively lower our U.S. net operating loss carry-forwards at December 31, 2004 by $52.7 million. This settlement agreement is not final until review and approval by the Congressional Joint Committee on Taxation, the timing of which is uncertain. We believe that we have estimated and provided adequate accruals for the additional taxes and interest expense that will result from these adjustments. Our estimated tax liability is subject to change as examinations of specific tax years are completed in the respective jurisdictions. We believe that any additional taxes or related interest over the amounts accrued will not have a material effect on our financial condition or results of operations, nor do we expect that examinations to be completed in the near term would have a material favorable impact. In addition, changes in the mix of income from our foreign subsidiaries, expiration of tax holidays and changes in tax laws or regulations could result in increased effective tax rates in the future.

     Recent Accounting Pronouncements. In March 2004, the Emerging Issues Task Force (“EITF”) reached a consensus on Issue 03-01, The Meaning of Other-Than-Temporary Impairment and Its Application to Certain Investments. EITF 03-01 provides guidance on other-than-temporary impairment models for marketable debt and equity securities accounted for under SFAS No. 115, Accounting for Certain Investments in Debt and Equity Securities, and SFAS No. 124, Accounting for Certain Investments Held by Not-for-Profit Organizations, and non-marketable equity securities accounted for under the cost method. The EITF developed a basic three-step model to evaluate whether an investment is other-than temporarily impaired. On September 30, 2004, the FASB approved the issuance of the FASB Staff Position (“FSP”) EITF 03-01-1, which delays the effective date until additional guidance is issued for the application of the recognition and measurement provisions of EITF 03-01 to investments in securities that are impaired. We will apply the guidance in EITF 03-01 to our investments when it becomes effective. See Note 6 for the investments held by us which would be effected by EITF 03-01.

     In December 2004, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 123R, Share-Based Payment. SFAS No. 123R is a revision of SFAS No. 123, Accounting for Stock Based Compensation and supersedes APB 25. Among other items, SFAS No. 123R eliminates the use of APB 25 and the intrinsic value method of accounting and requires companies to recognize the cost of employee services received in exchange for awards of equity instruments, based on the grant date fair value of those awards, in the financial statements. On April 14, 2005, the Securities and Exchange Commission (“SEC”) amended the effective date of SFAS No. 123R to January 1, 2006, for calendar year companies. We intend to adopt this statement on the new effective date.

     We currently utilize a standard option pricing model (Black-Scholes) to measure the fair value of stock options granted to employees. While SFAS No. 123R permits entities to continue to use such a model, the standard also permits the use of a “lattice” model. We have not yet determined which model we will use to measure the fair value of employee stock options upon the adoption of SFAS No. 123R.

     SFAS No. 123R also requires the benefits associated with the tax deductions in excess of recognized compensation cost be reported as a financing cash flow, rather than as an operating cash flow as required under current literature. This requirement will reduce net operating cash flows and increase net financing cash flows in periods after the effective date. These future amounts cannot be estimated because they depend on when the employees exercise stock options, among other things.

     We are currently reviewing the effect SFAS No. 123R will have on our financial statements; however, we believe the impact to our net income (loss) will be determined by the number of options that we grant in the future. In August 2004 we accelerated the vesting of all outstanding employee stock options, thereby eliminating charges to our future statements of operations related to these stock options. In addition to eliminating future compensation charges upon the adoption of SFAS No. 123 R, we also undertook the acceleration to enhance employee morale and to help retain high-potential individuals in the face of a downturn in industry conditions.

     Stock Compensation. We apply Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations, to our stock option plans. No compensation expense has been recognized for our employee stock options that have been granted. If compensation costs for our stock option plans had been determined using the fair value method of accounting as set forth in SFAS No. 123, Accounting for Stock-Based Compensation, our reported net income (loss) and per share amounts would have been decreased (increased).

     The following table illustrates the effect on net income (loss) and per share amounts if the fair value based method had been applied to all outstanding and unvested awards in each period.

7


Table of Contents

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands, except per share data)  
 
               
Net income (loss):
               
Net income (loss), as reported
  $ (119,070 )   $ 10,910  
Deduct: Total stock-based employee compensation determined under fair value based method, net of related tax effects
    (544 )     (7,757 )
 
           
Net income (loss), pro forma
  $ (119,614 )   $ 3,153  
 
           
 
               
Earnings (loss) per share:
               
Basic and diluted:
               
As reported
  $ (0.68 )   $ 0.06  
Pro forma
  $ (0.68 )   $ 0.02  

     In order to calculate the fair value of stock options at date of grant, we used the Black-Scholes option pricing model. The following assumptions were used to calculate weighted average fair values of the options granted:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
 
               
Expected life (in years)
    4       4  
Risk-free interest rate
    3.8 %     2.5 %
Volatility
    96 %     56 %
Dividend yield
           

2. Comprehensive Income (Loss)

     The following table summarizes comprehensive income (loss) for the periods presented:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
 
               
Net income (loss)
  $ (119,070 )   $ 10,910  
Unrealized gain (loss) on investments, net of tax
    (2,108 )     4,679  
Foreign currency translation adjustment, net of tax
    (1,383 )     3,061  
 
           
Total comprehensive income (loss)
  $ (122,561 )   $ 18,650  
 
           

3. Inventories

     Inventories consist of the following:

8


Table of Contents

                 
    March 31,     December 31,  
    2005     2004  
    (In thousands)  
 
               
Raw materials and purchased components
  $ 108,456     $ 114,808  
Work-in-process
    25,333       21,150  
Finished goods
    1,497       960  
 
           
 
    135,286       136,918  
Inventory reserve
    (23,648 )     (25,302 )
 
           
 
  $ 111,638     $ 111,616  
 
           

4. Property, Plant and Equipment

     Property, plant and equipment consist of the following:

                 
    March 31,     December 31,  
    2005     2004  
    (In thousands)  
 
               
Land
  $ 112,148     $ 112,009  
Land use rights
    19,945       19,945  
Buildings and improvements
    641,974       633,528  
Machinery and equipment
    1,970,264       1,953,392  
Furniture, fixtures and other equipment
    172,512       165,446  
Construction in progress
    97,067       102,952  
 
           
 
    3,013,910       2,987,272  
Less: Accumulated depreciation and amortization
    (1,641,761 )     (1,606,876 )
 
           
 
  $ 1,372,149     $ 1,380,396  
 
           

     The following table reconciles our activity related to property, plant and equipment payments as presented on the statement of cash flows to property, plant and equipment additions as reflected in the balance sheet:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
 
               
Payments for property, plant and equipment
  $ 66,712     $ 143,851  
Increase (decrease) in property, plant and equipment in accounts payable and accrued expenses
    (19,681 )     26,987  
 
           
Property, plant and equipment additions
  $ 47,031     $ 170,838  
 
           

5. Goodwill and Intangibles

     Our goodwill balance relates to our packaging services reporting unit. The change in the carrying value of goodwill is as follows:

         
    (In thousands)  
 
       
Balance as of December 31, 2004
  $ 656,052  
Translation adjustments
    (194 )
 
     
Balance as of March 31, 2005
  $ 655,858  
 
     

9


Table of Contents

     Intangibles as of March 31, 2005 consist of the following:

                         
            Accumulated        
    Gross     Amortization     Net  
    (In thousands)  
 
                       
Patents and technology rights
  $ 72,960     $ (35,651 )   $ 37,309  
Customer relationship and supply agreement
    8,858       (1,249 )     7,609  
 
                 
 
  $ 81,818     $ (36,900 )   $ 44,918  
 
                 

     Intangibles as of December 31, 2004 consist of the following:

                         
            Accumulated        
    Gross     Amortization     Net  
    (In thousands)  
 
                       
Patents and technology rights
  $ 72,973     $ (33,595 )   $ 39,378  
Customer relationship and supply agreement
    8,858       (934 )     7,924  
 
                 
 
  $ 81,831     $ (34,529 )   $ 47,302  
 
                 

     Amortization expense was $2.4 million and $1.4 million for the three months ended March 31, 2005 and 2004, respectively.

     Based on the amortizing assets recognized in our balance sheet at March 31, 2005, amortization expense for each of the next five fiscal years is estimated as follows:

         
    (In thousands)  
2005 (remaining)
  $ 6,129  
2006
    8,186  
2007
    8,183  
2008
    8,183  
2009
    3,276  

6. Investments

     Investments consist of the following:

                 
    March 31,     December 31,  
    2005     2004  
    (In thousands)  
Marketable securities classified as available for sale:
               
ASI (ownership of 2% at March 31, 2005 and December 31, 2004)
  $ 10,841     $ 12,940  
Other marketable securities classified as available for sale
    713       722  
 
           
Total marketable securities
    11,554       13,662  
Other investments
    92       100  
 
           
 
  $ 11,646     $ 13,762  
 
           

7. Accrued Expenses

     Accrued expenses consist of the following:

                 
    March 31,     December 31,  
    2005     2004  
    (In thousands)  
 
               
Accrued income taxes
  $ 35,014     $ 35,387  
Accrued payroll
    26,810       25,648  
Accrued interest
    34,055       34,547  
Accrued legal settlements (Note 12)
    50,000        
Other accrued expenses
    63,787       79,493  
 
           
 
  $ 209,666     $ 175,075  
 
           

10


Table of Contents

8. Corporate Relocation Expenses

     During the third quarter of 2004, we commenced efforts to relocate certain corporate functions from our West Chester, Pennsylvania location to our Chandler, Arizona location. In connection with these efforts, we expect to pay $1.2 million in severance and related costs. Of this $1.2 million, we recorded a charge of $0.9 million to selling, general and administrative expenses during 2004, and we charged the remaining $0.3 million to selling, general and administrative expenses during the first quarter of 2005. For the three months ended March 31, 2005, we paid out $0.8 million in severance benefits. As of March 31, 2005 we have $0.4 million accrued in severance and related costs which we expect to be paid in the second quarter of 2005.

9. Debt

     The major components of debt consist of the following:

                 
    March 31,     December 31,  
    2005     2004  
    (In thousands)  
Senior secured credit facilities:
               
Term loan, LIBOR plus 4.5% due October 2010
  $ 300,000     $ 300,000  
$30.0 million revolving line of credit, LIBOR plus 3.5% due June 2007
           
9.25% Senior notes due February 2008
    470,500       470,500  
7.75% Senior notes due May 2013
    425,000       425,000  
7.125% Senior notes due March 2011, net of unamortized discount of $1.5 million
    248,504       248,454  
10.5% Senior subordinated notes due May 2009
    200,000       200,000  
5.75% Convertible subordinated notes due June 2006, convertible at $35.00 per share
    233,000       233,000  
5% Convertible subordinated notes due March 2007, convertible at $57.34 per share
    146,422       146,422  
Notes payable, net of unamortized discount of $0.3 million
    16,050       15,675  
Other debt
    45,180       53,909  
 
           
 
    2,084,656       2,092,960  
Less: Short-term borrowings and current portion of long-term debt
    (42,245 )     (52,147 )
 
           
 
  $ 2,042,411     $ 2,040,813  
 
           

     We have a significant amount of indebtedness and expect this will continue for the foreseeable future. Our indebtedness requires us to dedicate a substantial portion of our cash flow from operations to service debt and interest payments.

     Our 5.75% Convertible subordinated notes (“Notes”) are due in June 2006. We are currently evaluating alternatives to meet this payment obligation.

     Senior Secured Credit Facilities

     On April 22, 2003, we entered into a new $200.0 million senior secured credit facility consisting of a $170.0 million term loan maturing January 31, 2006 (the “2006 Term Loan”) and a $30.0 million revolving line of credit that was available through October 2005. The funds available under this new credit facility were used to repay a $96.9 million term loan previously outstanding and for general corporate purposes. In March 2004, with the proceeds from our 7.125% senior notes (discussed further below), we satisfied in full the 2006 Term Loan, which carried a balance of $168.7 million. In connection with the satisfaction of the 2006 Term Loan, we recorded charges during the first quarter of 2004 of $1.7 million for the associated premiums paid and $1.0 million for the associated unamortized deferred debt issuance costs.

     In June 2004, we entered into a new $30.0 million senior secured revolving credit facility (the “Facility”). The Facility, which is available through June 2007, replaced our prior $30.0 million secured revolving line of credit which was scheduled to mature on October 31, 2005. At March 31, 2005, there was $29.7 million available under this Facility. As of March 31, 2005, we have outstanding $0.3 million of standby letters of credit. Such standby letters of credit are used in our ordinary course of business and are collateralized by our cash balances.

11


Table of Contents

     In October 2004, we entered into a new $300.0 million term loan credit facility with a group of institutional lenders. The term loan bears interest at a rate of LIBOR plus 450 basis points and matures in October 2010. The net proceeds of $288.8 million from the term loan were raised for working capital and general corporate purposes.

     Senior Notes

     In March 2004, we sold $250.0 million of 7.125% senior notes due March 2011. The notes were priced at 99.321% of the $250.0 million face value, yielding an effective interest rate of 7.25%. We sold these notes in a private placement and the notes were resold to qualified institutional investors. We used the net proceeds of the issuance to satisfy in full our outstanding term loan due 2006 of $168.7 million and used the remainder of the proceeds for general corporate purposes, including working capital and capital expenditures. The notes have a coupon rate of 7.125% annually and interest payments are due semi-annually. In connection with the offering of these notes, we entered into a registration rights agreement with the purchasers. The registration rights agreement entitled the purchasers, within 210 days from the original issuance, to exchange their notes for registered notes with substantially identical terms as the original notes. We filed a registration statement with the Securities and Exchange Commission for the exchange of the notes, and the exchange was completed in July 2004.

     At March 31, 2005 we were in compliance with all debt covenants contained in our loan agreements and have met all debt payment obligations.

     Notes Payable and Other Debt

     At March 31, 2005 our notes payable balance primarily consists of a $15.2 million note (net of a $0.3 million unamortized debt discount) related to our Unitive acquisitions, of which $15.5 million is due in the third quarter of 2005. At March 31, 2005 our other debt primarily relates to our foreign subsidiaries. The significant components of other debt include term debt and a revolving line of credit. One of our Japanese subsidiaries utilizes the revolving line of credit for working capital purposes and term debt for equipment financing. The revolving line of credit is due in the fourth quarter of 2005 and we expect to extend the agreement or refinance the amount owed. In addition, our Taiwanese subsidiaries have various amounts of term debt maturing between 2005 and 2010. These debt instruments do not include significant financial covenants.

10. Pension and Severance Plans

     Our Philippine, Taiwan and Japanese subsidiaries sponsor defined benefit plans that cover substantially all of their respective employees who are not covered by statutory plans. Charges to expense are based upon costs computed by independent actuaries. The components of net periodic pension cost for these defined benefit plans are as follows:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
 
               
Service cost
  $ 1,417     $ 1,837  
Interest cost on projected benefit obligation
    517       479  
Expected return on plan assets
    (309 )     (303 )
Amortization of transition obligation
    36       28  
Recognized loss
    12       7  
 
           
Total pension expense
  $ 1,673     $ 2,048  
 
           

     For the three months ended March 31, 2005 $0.3 million was contributed to fund the pension plans. We anticipate contributing an additional $4.8 million in 2005 to fund the pension plans.

     Our Korean subsidiary participates in an accrued severance plan that covers employees and directors with one year or more of service. Eligible plan participants are entitled to receive a lump-sum payment upon termination of their employment, based on their length of service and rate of pay at the time of termination. Accrued severance benefits are estimated assuming all eligible employees were to terminate their employment at the balance sheet date. The contributions to the national pension fund made under the National Pension Plan of the Republic of Korea are deducted from accrued severance benefit liabilities. For the three months ended March 31, 2005 and 2004, the provision recorded for severance

12


Table of Contents

benefits was $7.1 million and $4.3 million, respectively. The balance recorded in long-term liabilities for accrued severance was $99.5 million and $92.0 million at March 31, 2005 and December 31, 2004, respectively.

11. Earnings Per Share

     Statement of Financial Accounting Standards (SFAS) No. 128, “Earnings Per Share,” requires dual presentation of basic and diluted earnings per share on the face of the income statement. Basic EPS is computed using only the weighted average number of common shares outstanding for the period, while diluted EPS is computed assuming conversion of all dilutive securities, such as options, convertible debt and warrants. For the three months ended March 31, 2005, we excluded from the computation of diluted earnings per share 17.4 million and 9.2 million for outstanding options and convertible notes for common stock, respectively, potentially dilutive securities which would have an antidilutive effect on EPS due to our net loss for the period. For the three months ended March 31, 2004, potentially dilutive securities related to outstanding options, our convertible notes and warrants of 10.4 million, 9.2 million and 3.9 million, respectively, were antidilutive and therefore excluded from the diluted earnings per share calculation.

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
 
               
Weighted average common shares
    175,718       174,622  
Effect of dilutive stock options
          5,580  
 
           
Weighted average shares applicable to diluted earnings per share
    175,718       180,202  
 
           

12. Indemnifications, Guarantees and Contingencies

Indemnifications and Guarantees

     We have indemnified members of our board of directors and our corporate officers against any threatened, pending or completed action or proceeding, whether civil, criminal, administrative or investigative by reason of the fact that the indemnitee is or was a director or officer of the company. These officers and directors are indemnified, to the fullest extent permitted by law, against related expenses, judgments, fines and any amounts paid in settlement. We also maintain Directors and Officers insurance coverage in order to mitigate our exposure to these indemnification obligations. The maximum amount of future payments is generally unlimited. Due to the nature of this indemnification, it is not possible to make a reasonable estimate of the maximum potential loss or range of loss. No assets are held as collateral and no specific recourse provisions exist related to this indemnification.

     We generally provide a standard ninety-day warranty on our services. Our warranty activity has historically been immaterial and is expected to continue to be immaterial in the foreseeable future.

Litigation

     We are currently a party to various legal proceedings, including those noted below. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net results in the period in which the ruling occurs. The estimate of the potential impact from the following legal proceedings on our financial position or overall results of operations could change in the future. Attorney fees related to legal matters are expensed as incurred.

Epoxy Mold Compound Litigation

     We have become party to an increased number of litigation matters relative to our historic levels. Much of our recent increase in litigation relates to an allegedly defective epoxy mold compound, formerly used in some of our packaging services, which is alleged to be responsible for certain semiconductor chip failures. In the case of each of the pending matters, we believe we have meritorious defenses, as well as valid third-party claims against Sumitomo Bakelite Co., Ltd. (“Sumitomo Bakelite”), the manufacturer of the challenged epoxy product, should the epoxy mold compound be found to be defective. We cannot be certain, however, that we will be able to recover any amount from Sumitomo Bakelite if we are held liable in these matters, or that any adverse result would not have a material impact upon us. Moreover, other customers of

13


Table of Contents

ours have made inquiries about the epoxy mold compound, which was widely used in the semiconductor industry, and no assurance can be given that claims similar to those already asserted will not be made against us by other customers in the future.

     Fujitsu Limited v. Cirrus Logic, Inc., et al.

     On April 16, 2002, we were served with a third-party complaint in an action entitled Fujitsu Limited v. Cirrus Logic, Inc., in the United States District Court for the Northern District of California, San Jose Division. Subsequently, substantially the same case was filed in the Superior Court of California, Santa Clara County, and the United States District Court case was stayed. In this action, Fujitsu Limited (“Fujitsu”) alleged that semiconductor devices it purchased from Cirrus Logic, Inc. (“Cirrus Logic”) were defective in that a certain epoxy mold compound manufactured by Sumitomo Bakelite and used by Amkor in the manufacture of the chip causes a short circuit which renders Fujitsu disk drive products inoperable. Cirrus Logic, in response, denied the allegations of the complaint, counterclaimed against Fujitsu for unpaid invoices, and filed its third-party complaint against us alleging that any liability for chip defects should be assigned to us because we assembled the subject semiconductor devices. We filed a cross-complaint against Sumitomo Bakelite asserting claims for breach of warranties and indemnification.

     On April 18 and 19, 2005, we participated in a private mediation with all parties involved. As a result of the mediation, on April 28, 2005 an agreement was reached among Fujitsu, Cirrus Logic, Sumitomo Bakelite and ourselves to settle this litigation; the parties entered the agreement into the record in Superior Court. We have agreed to pay $40 million to Fujitsu in consideration of a release from and dismissal of all claims related to this litigation. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005. The $40 million is expected to be paid during the second quarter of fiscal 2005.

     Seagate Technology LLC v. Atmel Corporation, et al.

     In March 2003, we were served with a cross-complaint in an action between Seagate Technology LLC and Seagate Technology International (“Seagate”) and Atmel Corporation and Atmel Sarl (“Atmel”) in the Superior Court of California, Santa Clara County. Atmel’s cross-complaint seeks indemnification from us for any damages incurred from the claims by Seagate involving the allegedly defective epoxy mold compound manufactured by Sumitomo Bakelite. We answered Atmel’s cross-complaint, denying all liability, and filed a cross-complaint against Sumitomo Bakelite. Atmel later amended its cross-complaint to include claims for negligence and negligent misrepresentation against us and added ChipPAC Inc. (“ChipPAC”) and Sumitomo Bakelite as cross-defendants. ChipPAC filed a cross-complaint against Sumitomo Bakelite and us.

     On April 14, 2005 an agreement was reached among Seagate, Atmel, ChipPAC, Sumitomo Bakelite and ourselves to settle this litigation. We have agreed to pay $5 million to Seagate in consideration of a release from and dismissal of all claims related to this litigation. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005. The $5 million is expected to be paid during the second quarter of fiscal 2005.

     Maxtor Corporation v. Koninklijke Philips Electronics N.V., et al.

     In April 2003, we were served with a cross-complaint in an action between Maxtor Corporation (“Maxtor”) and Koninklijke Philips Electronics (“Philips”) in the Superior Court of California, Santa Clara County. Philips’ cross-complaint sought indemnification from us for any damages incurred from the claims by Maxtor involving the allegedly defective epoxy mold compound manufactured by Sumitomo Bakelite. Philips subsequently filed a cross-complaint directly against Sumitomo Bakelite, alleging, among other things, that Sumitomo Bakelite breached its contractual obligations to both us and Philips by supplying a defective mold compound resulting in the failure of certain Philips semiconductor devices. We denied all liability in this matter and also asserted a cross-complaint against Sumitomo Bakelite. Sumitomo Bakelite denied any liability. Maxtor and Philips reached a settlement of Maxtor’s claims against Philips on or about April 28, 2004 in which, reportedly, Philips agreed to pay Maxtor $24.8 million. On October 15, 2004, we and Sumitomo Bakelite reached a settlement agreement whereby Sumitomo Bakelite agreed to indemnify us for any damages awarded to Philips in excess of $3.5 million. In exchange, we dismissed our cross-claims against Sumitomo Bakelite. Trial of this matter before a jury began on October 18, 2004 and closing arguments were heard on November 29, 2004. On December 1, 2004, the Court and the jury rendered verdicts in our favor related to all of Philips’ claims against us. By those verdicts, we were exonerated of all alleged liability. The jury’s verdict further determined Sumitomo Bakelite’s share of liability to be 57% and Philips’ share to be 43%. Philips

14


Table of Contents

has agreed not to appeal the judgment in our favor in return for our agreement not to seek costs of suit from Philips. In January 2005, Sumitomo Bakelite appealed the judgment against it.

     We recorded a charge of $1.5 million related to the above matter during the three months ended March 31, 2004. However, in response to the December 1, 2004 verdict, we reversed this charge during the three months ended December 31, 2004.

Pending Epoxy Mold Litigation

     While the ultimate outcome is uncertain, as a result of the previously discussed epoxy mold compound litigation settlements, we have established a $5 million loss accrual related to the following two pending claims. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005.

     Maxim Integrated Products, Inc. v. Amkor Technology, Inc., et al.

     In August 2003, we were served with a complaint filed by Maxim Integrated Products, Inc. (“Maxim”) against us, Sumitomo Bakelite and Sumitomo Plastics America, Inc. (“Sumitomo Plastics”) in the Superior Court of California, Santa Clara County. The complaint seeks damages related to our use of Sumitomo Bakelite’s epoxy mold compound in assembling Maxim’s semiconductor packages. Written discovery is ongoing, with depositions and expert discovery to follow. The Court has set a trial date of April 24, 2006. We have denied all liability. We intend to defend ourselves vigorously, pursue our cross-claims against Sumitomo Bakelite and seek judgment in our favor.

     Fairchild Semiconductor Corporation v. Sumitomo Bakelite Singapore Pte. Ltd., et al.

     In September 2003, we were served with an amended complaint filed by Fairchild Semiconductor Corporation (“Fairchild”) against us, Sumitomo Bakelite, Sumitomo Plastics and Sumitomo Bakelite Singapore Pte. Ltd. in the Superior Court of California, Santa Clara County. The amended complaint seeks damages related to our use of Sumitomo Bakelite’s epoxy mold compound in assembling Fairchild’s semiconductor packages. Trial is currently scheduled to commence on November 7, 2005, and to last 15 court days. We have denied all liability. We intend to defend ourselves vigorously, pursue our cross-claims against Sumitomo Bakelite and seek judgment in our favor.

Other Litigation

     Amkor Technology, Inc. v. Motorola, Inc.

     In August 2002, we filed a complaint against Motorola, Inc. (“Motorola”) seeking declaratory judgment relating to a controversy between us and Motorola concerning: (i) the assignment by Citizen Watch Co., Ltd. (“Citizen”) to us of a Patent License Agreement dated January 25, 1996 between Motorola and Citizen (the “License Agreement”) and concurrent assignment by Citizen to us of Citizen’s interest in U.S. Patents 5,241,133 and 5,216,278 (the “‘133 and ‘278 patents”); and (ii) our obligation to make certain payments pursuant to an immunity agreement (the “Immunity Agreement”) dated June 30, 1993 between us and Motorola, pending in the Superior Court of the State of Delaware in and for New Castle County.

     We and Motorola resolved the controversy with respect to all issues relating to the Immunity Agreement, and all claims and counterclaims filed by the parties in the case relating to the Immunity Agreement were dismissed or otherwise disposed of without further litigation. The claims relating to the License Agreement and the ‘133 and ‘278 Patents remained pending.

     We and Motorola both filed motions for summary judgment on the remaining claims, and oral arguments were heard in September 2003. On October 6, 2003, the Superior Court of Delaware ruled in favor of us and issued an Opinion and Order granting our motion for summary judgment and denying Motorola’s motion for summary judgment. On October 22, 2003, Motorola filed an appeal in the Supreme Court of Delaware. In May 2004, the Supreme Court reversed the Superior Court’s decision, and remanded for further development of the factual record. A trial date has been set for October 17, 2005. We believe we will prevail on the merits at the Superior Court level. In addition, should Motorola prevail, we believe we will have recourse against Citizen.

     Citizen Watch Co. Ltd. v. Amkor Technology, Inc.

15


Table of Contents

     We entered into an intellectual property assignment agreement (“IPAA”) with Citizen Watch Co., Ltd. (“Citizen”) with an effective date of March 28, 2002, pursuant to which Citizen assigned to us (i) its rights under a Patent License Agreement dated January 25, 1996 between Motorola and Citizen (the “License Agreement”) and (ii) Citizen’s interest in the ‘133 and ‘278 patents. The parties entered into the IPAA in conjunction with having entered into a Master Purchase Agreement under which we purchased substantially all of the assets of a division of Citizen in April 2002. Subsequent to that transaction, Motorola challenged the validity of Citizen’s assignment of its rights under the License Agreement to us, which resulted in our litigation with Motorola, Inc., which is described above (the “Motorola case”). Pending resolution of the Motorola case, and in accordance with the terms of the IPAA, we are withholding final payment of 1.4 billion yen ($13.0 million based on the spot exchange rate at March 31, 2005).

     In March 2004, Citizen submitted a Demand for Arbitration in the International Chamber of Commerce (“ICC”), claiming breach of our obligation to make the deferred payment of 1.4 billion yen. In May 2004, we filed our Answer to Request for Arbitration, Counterclaim and Request for Abeyance of Proceedings. In our Answer, we contend, among other things, that we do not have an obligation to make the deferred payment due to (i) our inability to perfect the rights assigned by Citizen under the License Agreement, and (ii) Citizen’s breach of its representations and warranties that it had all right and authority to assign its rights under the License Agreement to us.

     The arbitration hearing before the ICC on this matter was held in May 2005. A ruling by the ICC is expected by July 31, 2005.

     Alcatel Business Systems v. Amkor Technology, Inc., Anam Semiconductor, Inc.

     On November 5, 1999, we agreed to sell certain semiconductor parts to Alcatel Microelectronics, N.V. (“AME”), a subsidiary of Alcatel S.A. The parts were manufactured for us by Anam Semiconductor, Inc. (“ASI”) and delivered to AME. AME transferred the parts to another Alcatel subsidiary, Alcatel Business Systems (“ABS”), which incorporated the parts into cellular phone products. In early 2001, a dispute arose as to whether the parts sold by us were defective. On March 18, 2002, ABS and its insurer filed suit against us and ASI in the Paris Commercial Court of France, claiming damages of approximately 50.4 million Euros (approximately $65.1 million based on the spot exchange rate at March 31, 2005). We have denied all liability and intend to vigorously defend ourselves and have not established a loss accrual associated with this claim. Additionally, we have entered into a written agreement with ASI whereby ASI has agreed to indemnify us fully against any and all loss related to the claims of AME, ABS and ABS’ insurer. The Paris Commercial Court commenced a special proceeding before a technical expert to report on the facts of the dispute. The report of the court-appointed expert was put forth on December 31, 2003. The report does not specifically allocate liability to any particular party. On May 18, 2004, the Paris Commercial Court of France declared that it did not have jurisdiction over the matter. The Court of Appeal of Paris heard the appeal regarding jurisdiction during October 2004, confirmed the first tier ruling and dismissed the appeal. A motion was recently filed by ABS and its insurer before the French Supreme Court to challenge the lack of jurisdiction ruling.

     In response to the French lawsuit, on May 22, 2002, we filed a petition to compel arbitration in the United States District Court for the Eastern District of Pennsylvania (the “Court”) against ABS, AME and ABS’ insurer, claiming that the dispute is subject to the arbitration clause of the November 5, 1999 agreement between us and AME. ABS and ABS’ insurer have refused to arbitrate and continue to challenge the lack of jurisdiction ruling.

     Amkor Technology, Inc. v. Carsem (M) Sdn Bhd, Carsem Semiconductor Sdn Bhd, and Carsem Inc.

     In November 2003, we filed complaints against Carsem (M) Sdn Bhd, Carsem Semiconductor Sdn Bhd, and Carsem Inc. (collectively “Carsem”) with the International Trade Commission (“ITC”) in Washington, D.C. and subsequently in the Northern District of California. The complaints allege infringement of our United States Patent Nos. 6,433,277, 6,455,356, and 6,630,728 (collectively the “Amkor Patents”). We allege that by making, using, selling, offering for sale, or importing into the U.S. the Carsem Dual and Quad Flat No-Lead Package, Carsem has infringed on one or more of our MicroLeadFrame® packaging technology claims in the Amkor Patents. The District Court action had been stayed pending resolution of the ITC case. The ITC Administrative Law Judge conducted an evidentiary hearing during July and August of 2004 in Washington D.C. and issued an initial determination that Carsem infringed some of our patent claims relating to our MicroLeadFrame® package technology, that some of our 21 asserted patent claims are valid, and that all of our asserted patent claims are enforceable. However, the judge did not find a statutory violation of the Tariff Act. We filed a petition in November 2004 to have the judge’s ruling reviewed by the full International Trade Commission. The Commission has ordered a new claims construction related to various disputed claim terms and has remanded the case to the Administrative

16


Table of Contents

Law Judge for further proceedings. The Commission has set a new date of November 21, 2005 for completion of the investigation. The District court action remains stayed pending completion of the ITC investigation.

     Other Matters

     In June 2004, the Securities and Exchange Commission informed us that it was conducting an informal inquiry into certain trading in Amkor securities. The focus of the inquiry appears to be activities during the first half of 2004. We have cooperated with the inquiry by voluntarily producing documents to the Commission and providing testimony. The Commission staff has not informed us of any conclusions of wrongdoing by any person or entity.

13. Related Party Transactions

     Mr. JooHo Kim is an executive officer of Amkor and a brother of James J. Kim, our Chairman and CEO. Mr. JooHo Kim owns with his children 19.2%, at March 31, 2005, of Anam Information Technology, Inc., a company that provides computer hardware and software components to Amkor Technology Korea, Inc. (a subsidiary of Amkor). For the three months ended March 31, 2005 and 2004, purchases from Anam Information Technology, Inc. were $0.1 million and $1.1 million, respectively. Amounts due to Anam Information Technology, Inc. at March 31, 2005, and December 31, 2004 were not significant.

     Mr. JooHo Kim, together with his wife and children, own 96.1%, at March 31, 2005, of Jesung C&M, a company that provides cafeteria services to Amkor Technology Korea, Inc. For the three months ended March 31, 2005 and 2004 purchases from Jesung C&M were $1.6 million and $1.6 million, respectively. Amounts due to Jesung C&M at March 31, 2005 and December 31, 2004 were $0.6 million and $0.6 million, respectively.

     Dongan Engineering Co., Ltd. is 100% owned by JooCheon Kim, a brother of James J. Kim. Mr. JooCheon Kim is not an employee of Amkor. Dongan Engineering Co., Ltd. provides construction and maintenance services to Amkor Technology Korea, Inc. and Amkor Technology Philippines, Inc., both subsidiaries of Amkor. For the three months ended March 31, 2005 and 2004 purchases from Dongan Engineering Co., Ltd were $0.2 million and $0.7 million, respectively. Amounts due to Dongan Engineering Co., Ltd. at March 31, 2005 and December 31, 2004 were $0.1 million and $0.2 million, respectively.

     We purchase leadframe inventory from Acqutek Semiconductor & Technology Co., Ltd. James J. Kim’s, our Chairman and Chief Executive Officer, ownership in Acqutek Semiconductor & Technology Co., Ltd. is approximately 17.7% at March 31, 2005. For the three months ended March 31, 2005 and 2004 purchases from Acqutek Semiconductor & Technology Co., Ltd. were $2.9 million and $3.5 million, respectively. Amounts due to Acqutek Semiconductor & Technology Co., Ltd. at March 31, 2005 and December 31, 2004 were $0.5 million and $0.6 million, respectively.

     We lease office space in West Chester, Pennsylvania from trusts related to James J. Kim. The lease expires in 2006. Amounts paid for this lease for the three months ended March 31, 2005 and 2004 were $0.3 million and $0.3 million, respectively. For the three months ended March 31, 2005 and 2004 our sublease income includes $0.1 million and $0.1 million respectively, from related parties.

17


Table of Contents

14. Subsidiary Guarantors

     Payment obligations under our senior and senior subordinated notes (see Note 9), totaling $1,344 million, are fully and unconditionally guaranteed by certain of our wholly-owned subsidiaries. The subsidiaries that guarantee our senior and senior subordinated notes consist of Unitive, Inc., Unitive Electronics, Inc., Amkor International Holdings, LLC, Amkor Technology Limited, P-Four, LLC and Amkor/Anam Pilipinas, L.L.C.

     Presented below is condensed consolidating financial information for the parent, the guarantor subsidiaries and the non-guarantor subsidiaries. Investments in subsidiaries are accounted for by the parent and subsidiaries on the equity method of accounting. Earnings of subsidiaries are, therefore, reflected in the parent’s and guarantor subsidiaries’ investments in subsidiaries’ accounts. The elimination columns eliminate investments in subsidiaries and inter-company balances and transactions. Separate financial statements and other disclosures concerning the guarantor subsidiaries are not presented because the guarantor subsidiaries are wholly-owned and have unconditionally guaranteed the senior notes and senior subordinated notes on a joint and several basis. There are no significant restrictions on the ability of any guarantor subsidiary to directly or indirectly make distributions to us.

                                         
    Condensed Consolidating Balance Sheet  
    March 31, 2005  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
                                       
Current assets:
                                       
Cash and cash equivalents
  $ 198,599     $ 21,650     $ 66,511     $     $ 286,760  
Accounts receivable
    126,110       42,265       102,674             271,049  
Inventories
    75,846       7,902       27,890             111,638  
Other current assets
    2,866       1,695       28,787             33,348  
 
                             
Total current assets
    403,421       73,512       225,862             702,795  
 
                             
Inter-company
    1,217,442       (98,857 )     (1,118,585 )                
Property, plant and equipment, net
    49,863       327,307       994,979             1,372,149  
Investments
    730,728       339,366       845,768       (1,904,216 )     11,646  
Goodwill and acquired intangibles, net
    37,188       24,288       594,382             655,858  
Other assets
    80,764       6,808       36,317             123,889  
 
                             
Total assets
  $ 2,519,406     $ 672,424     $ 1,578,723     $ (1,904,216 )   $ 2,866,337  
 
                             
 
                                       
Current liabilities:
                                       
Short term borrowings and current portion of long-term debt
  $ 15,177     $ 508     $ 26,560     $     $ 42,245  
Other current liabilities
    232,079       36,119       143,045             411,243  
 
                             
Total current liabilities
    247,256       36,627       169,605             453,488  
 
                             
Long-term debt
    2,024,300             18,111             2,042,411  
Other non-current liabilities
    882       11,564       105,217             117,663  
 
                             
Total liabilities
    2,272,438       48,191       292,933             2,613,562  
 
                             
Minority interest
                    5,807               5,807  
Total stockholders equity
    246,968       624,233       1,279,983       (1,904,216 )     246,968  
 
                             
Total liabilities and stockholders equity
  $ 2,519,406     $ 672,424     $ 1,578,723     $ (1,904,216 )   $ 2,866,337  
 
                             

18


Table of Contents

14. Subsidiary Guarantors — (continued)

                                         
    Condensed Consolidating Balance Sheet  
    December 31, 2004  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
 
                                       
Current assets:
                                       
Cash and cash equivalents
  $ 267,692     $ 26,217     $ 78,375     $     $ 372,284  
Accounts receivable
    125,927       30,835       112,733             269,495  
Inventories
    76,162       7,614       27,840             111,616  
Other current assets
    3,445       2,601       26,545             32,591  
 
                             
Total current assets
    473,226       67,267       245,493             785,986  
 
                             
Inter-company
    1,163,793       (88,206 )     (1,075,587 )            
Property, plant and equipment, net
    51,912       336,438       992,046             1,380,396  
Investments
    776,393       355,828       860,960       (1,979,419 )     13,762  
Goodwill
    37,188       24,280       594,584             656,052  
Other assets
    84,436       6,888       37,848             129,172  
 
                             
Total assets
  $ 2,586,948     $ 702,495     $ 1,655,344     $ (1,979,419 )   $ 2,965,368  
 
                             
 
                                       
Current liabilities:
                                       
Short term borrowings and current portion of long-term debt
  $ 14,965     $ 965     $ 36,217     $     $ 52,147  
Other current liabilities
    177,339       32,680       176,864             386,883  
 
                             
Total current liabilities
    192,304       33,645       213,081             439,030  
 
                             
Long-term debt
    2,024,244             16,569             2,040,813  
Other non-current liabilities
    871       10,307       98,139             109,317  
 
                             
Total liabilities
    2,217,419       43,952       327,789             2,589,160  
 
                             
Minority interest
                    6,679               6,679  
Total stockholders equity
    369,529       658,543       1,320,876       (1,979,419 )     369,529  
 
                             
Total liabilities and stockholders equity
  $ 2,586,948     $ 702,495     $ 1,655,344     $ (1,979,419 )   $ 2,965,368  
 
                             

19


Table of Contents

14. Subsidiary Guarantors — (continued)

                                         
    Condensed Consolidating Statement of Operations  
    For the three months ended March 31, 2005  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
Net sales
  $ 280,912     $ 111,445     $ 229,021     $ (203,897 )   $ 417,481  
Cost of sales
    249,396       113,323       212,472       (201,105 )     374,086  
 
                             
Gross profit (loss)
    31,516       (1,878 )     16,549       (2,792 )     43,395  
 
                             
Operating expenses:
                                       
Selling, general and administrative
    30,184       11,581       19,519       (2,792 )     58,492  
Research and development
    1,068       1,869       5,963             8,900  
Amortization of acquired intangibles
    777       118       1,079             1,974  
Provision for legal settlements and contingencies
    50,000                         50,000  
 
                             
Total operating expenses
    82,029       13,568       26,561       (2,792 )     119,366  
 
                             
Operating income (loss)
    (50,513 )     (15,446 )     (10,012 )           (75,971 )
 
                             
Other expense (income):
                                       
Interest expense, net
    24,543       1,019       14,951             40,513  
Foreign currency loss (gain)
    650       820       762             2,232  
Equity investment losses (income)
    42,178       16,996       15,146       (74,326 )     (6 )
Other expense (income), net
    877       665       (1,358 )           184  
 
                             
Total other expense (income)
    68,248       19,500       29,501       (74,326 )     42,923  
 
                             
Income (loss) before income taxes and minority interest
    (118,761 )     (34,946 )     (39,513 )     74,326       (118,894 )
Minority interest
                1,011             1,011  
 
                             
Income (loss) before income taxes
    (118,761 )     (34,946 )     (38,502 )     74,326       (117,883 )
Provision for income taxes (benefit)
    309       (26 )     904             1,187  
 
                             
Net income (loss)
  $ (119,070 )   $ (34,920 )   $ (39,406 )   $ 74,326     $ (119,070 )
 
                             

20


Table of Contents

14. Subsidiary Guarantors — (continued)

                                         
    Condensed Consolidating Statement of Operations  
    For the three months ended March 31, 2004  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
Net sales
  $ 300,119     $ 151,847     $ 260,419     $ (247,739 )   $ 464,646  
Cost of sales
    286,103       121,401       189,680       (244,386 )     352,798  
 
                             
Gross profit (loss)
    14,016       30,446       70,739       (3,353 )     111,848  
 
                             
Operating expenses:
                                       
Selling, general and administrative
    32,150       6,831       16,550       (3,353 )     52,178  
Research and development
    2,630       1,315       5,032             8,977  
Amortization of acquired intangibles
    761             567             1,328  
Provision for legal settlements and contingencies
    1,500                         1,500  
 
                             
Total operating expenses
    37,041       8,146       22,149       (3,353 )     63,983  
 
                             
Operating income (loss)
    (23,025 )     22,300       48,590               47,865  
 
                             
Other expense (income):
                                       
Interest expense, net
    19,802       515       12,973             33,290  
Foreign currency loss (gain)
    (1,003 )     (211 )     1,289             75  
Equity investment losses (income)
    (55,129 )     (28,368 )     (20,469 )     103,966        
Other expense (income), net
    2,313       144       (660 )           1,797  
 
                             
Total other expense (income)
    (34,017 )     (27,920 )     (6,867 )     103,966       35,162  
 
                             
Income (loss) before income taxes and minority interest
    10,992       50,220       55,457       (103,966 )     12,703  
Minority interest
                (358 )           (358 )
 
                             
Income (loss) before income taxes
    10,992       50,220       55,099       (103,966 )     12,345  
Provision for income taxes (benefit)
    82       1,365       (12 )           1,435  
 
                             
Net income (loss)
  $ 10,910     $ 48,855     $ 55,111     $ (103,966 )   $ 10,910  
 
                             

21


Table of Contents

14. Subsidiary Guarantors — (continued)

                                         
    Condensed Consolidating Statement of Cash Flows (restated)  
    For the three months ended March 31, 2005  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
Net cash flows provided by (used in)
                                       
operating activities
  $ (26,435 )   $ 1,671     $ 18,322     $     $ (6,442 )
Cash flows from investing activities:
                                       
Payments for plant, property and equipment
    (2,503 )     (7,762 )     (56,447 )           (66,712 )
Other investing activities
    (40,053 )     480       (293 )     40,022       156  
 
                             
Net cash used in investing activities
    (42,556 )     (7,282 )     (56,740 )     40,022       (66,556 )
 
                             
Cash flows from financing activities:
                                       
Net change in bank overdrafts and revolving credit facility
    (102 )           (8,210 )           (8,312 )
Payments of long-term debt
          (456 )     (3,048 )           (3,504 )
Other financing activities
          1,500       38,522       (40,022 )        
 
                             
Net cash from (used in) financing activities
    (102 )     1,044       27,264       (40,022 )     (11,816 )
 
                             
Effect of exchange rate fluctuations on cash and cash equivalents
                (710 )           (710 )
 
                             
Net change in cash and cash equivalents
    (69,093 )     (4,567 )     (11,864 )             (85,524 )
Cash and cash equivalents, beginning of period
    267,692       26,217       78,375             372,284  
 
                             
Cash and cash equivalents, end of period
  $ 198,599     $ 21,650     $ 66,511     $     $ 286,760  
 
                             

22


Table of Contents

14. Subsidiary Guarantors — (continued)

                                         
    Condensed Consolidating Statement of Cash Flows  
    For the three months ended March 31, 2004  
    (In thousands)  
            Guarantor     Non-Guarantor              
    Parent     Subsidiaries     Subsidiaries     Eliminations     Consolidated  
Net cash flows provided by (used in)
                                       
operating activities
  $ (48,104 )   $ 54,671     $ 90,771     $     $ 97,338  
 
                             
Cash flows from investing activities:
                                       
Payments for plant, property and equipment
    (6,027 )     (31,287 )     (106,537 )           (143,851 )
Acquisitions, net of cash acquired
    (12,858 )                       (12,858 )
Proceeds from note receivable
                18,627             18,627  
Other investing activities
    (34,644 )     (1,054 )     1,723       34,660       685  
 
                             
Net cash used in investing activities
    (53,529 )     (32,341 )     (86,187 )     34,660       (137,397 )
 
                             
Cash flows from financing activities:
                                       
Net change in bank overdraft and revolving credit facility
    (2,155 )           (5,395 )           (7,550 )
Proceeds from issuance of long-term debt
    248,315             3,844             252,159  
Payments for debt issuance costs
    (3,152 )                       (3,152 )
Payments of long-term debt, including redemption premium payment
    (170,429 )           (1,122 )           (171,551 )
Net proceeds from issuance of common stock
    1,846                         1,846  
Other financing activities
                34,660       (34,660 )      
 
                             
Net cash provided by financing activities
    74,425             31,987       (34,660 )     71,752  
 
                             
Effects of exchange rate fluctuations on cash and cash equivalents
                544             544  
 
                             
Net change in cash and cash equivalents
    (27,208 )     22,330       37,115               32,237  
Cash and cash equivalents, beginning of period
    203,840       26,190       83,229             313,259  
 
                             
Cash and cash equivalents, end of period
  $ 176,632     $ 48,520     $ 120,344     $     $ 345,496  
 
                             

23


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     The following discussion contains forward-looking statements within the meaning of the federal securities laws, including but not limited to statements regarding: (1) the condition and growth of the industry in which we operate, including trends toward increased outsourcing, reductions in inventory and demand and selling prices for our services, (2) our anticipated capital expenditures and financing needs, (3) our belief as to our future capacity utilization rates, revenue, gross margins and operating performance and (4) other statements that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. Because such statements include risks and uncertainties, actual results may differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in the following discussion as well as in “Risk Factors that May Affect Future Operating Performance.” The following discussion provides information and analysis of our results of operations for the three months ended March 31, 2005 and our liquidity and capital resources. You should read the following discussion in conjunction with our consolidated financial statements and the related notes, included elsewhere in this quarterly report as well as other reports we file with the Securities and Exchange Commission.

2005 Restatement

     We are filing this amendment on Form 10-Q/A to our Quarterly Report on Form 10-Q to restate our condensed consolidated financial statements for the three months ended March 31, 2005. In connection with finalizing the restatement of our previously filed financial statements for each of the three years in the period ended December 31, 2004, as included in our amended Annual Report on Form 10-K/A filed on June 6, 2005, we have revised the amount of unpaid capital expenditures utilized in preparing our condensed consolidated statement of cash flows for the three months ended March 31, 2005 that was included in our Quarterly Report on Form 10-Q filed on May 16, 2005. In conjunction with the restatement of our Annual Report, as described above, we restated our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, and September 30 of 2004. We filed amendments on Form 10-Q/A to these Quarterly Reports on June 6, 2005.

     See Note 1 to the unaudited condensed consolidated financial statements included within Part I, Item 1 of this report.

Company Overview

     Amkor is one of the world’s largest subcontractors of semiconductor packaging and test services. The company has built a leading position by:

  •   Providing a broad portfolio of packaging and test technologies and services;
 
  •   Maintaining a leading role in the design and development of new package and test technologies;
 
  •   Cultivating long-standing relationships with customers, including many of the world’s leading semiconductor companies;
 
  •   Developing expertise in high-volume manufacturing; and
 
  •   Diversifying our operational scope by establishing production capabilities in China, Japan, Taiwan and Singapore, in addition to long-standing capabilities in Korea and the Philippines.

     The semiconductors that we package and test for our customers ultimately become components in electronic systems used in communications, computing, consumer, industrial, automotive and military applications. Our customers include, among others, Agilent Technologies, Atmel Corporation, Conexant Systems, Inc., Infineon Technologies AG, Intel Corporation, Philips Electronics N.V., Samsung Electronics Corporation LTD, ST Microelectronics PTE, Texas Instruments Inc. and Toshiba Corporation. The outsourced semiconductor packaging and test market is very competitive. We also compete with the internal semiconductor packaging and test capabilities of many of our customers, some of whom can use us as a source of overflow capacity.

24


Table of Contents

     Packaging and test are an integral part of the semiconductor manufacturing process. Semiconductor manufacturing begins with silicon wafers and involves the fabrication of electronic circuitry into complex patterns, thus creating individual chips on the wafers. The packaging process creates an electrical interconnect between the semiconductor chip and the system board. In packaging, the fabricated semiconductor wafers are cut into individual chips which are then attached to a substrate and encased in a protective material to provide optimal electrical and thermal performance. Increasingly, packages are custom designed for specific chips and specific end-market applications. The packaged chips are then tested using sophisticated equipment to ensure that each packaged chip meets its design specifications.

Risk Factors That May Affect Future Operating Performance

     Our future results of operations involve a number of risks and uncertainties. Factors that could affect future results and cause actual results to vary materially from historical results include, but are not limited to, dependence on the highly cyclical nature of the semiconductor industry, fluctuation in operating results, the decline in average selling prices, our high leverage and the restrictive covenants contained in the agreements governing our indebtedness, the absence of significant backlog in our business, our dependence on international operations and sales, difficulties integrating acquisitions, our dependence on materials and equipment suppliers, capital expenditure requirements, the increased litigation incident to our business, rapid technological change, competition, our need to comply with existing and future environmental regulations, the enforcement of intellectual property rights by or against us and continued control by existing stockholders.

     Additional risks and uncertainties not presently known to us, or that we currently deem immaterial, may also impair our business operations. We cannot assure you that any of the events contemplated by the risks above will not occur. If they do, our business, financial condition or results of operations could be materially adversely affected. You should refer to Risk Factors That May Affect Future Operating Performance in our 2004 Annual Report on Form 10-K for a more detailed discussion of known material risks facing our company.

Our Expectations Regarding Future Business Conditions

     Our business is tied to market conditions in the semiconductor industry, which is highly cyclical. In considering industry growth estimates, we look at a group of nine leading industry analysts. These analysts have forecasted 2005 industry growth to range from negative 6% to positive 9%, with a median growth rate of 0%. These analysts have also forecasted 2006 industry growth to range from negative 9% to positive 16%, with a median growth rate of 5%. The strength of the semiconductor industry is dependent primarily upon the strength of the computer and communications systems markets as well as the strength of the worldwide economy.

     In addition to the historical trend in the semiconductor industry as a whole, the trend towards increased outsourcing of packaging and test services in the semiconductor industry has been a primary factor for our historical annual growth in revenues. We expect this trend to continue into the foreseeable future as we believe technological advances are driving our customers to outsource more of their packaging requirements.

     We currently expect sales for the second quarter of 2005 to be approximately 10% to 13% higher than sales for the first quarter of 2005 based on rising customer forecasts for a broad range of existing package products and also for turnkey flipchip and wafer level packaging programs that have resulted from our Unitive acquisition and IBM collaboration. We expect second quarter of 2005 gross margin in the range of 12% to 14% and net loss in the range of 28 to 32 cents per share. Profitability remains constrained by the combined effects of continued pricing pressure and a significant ramp in capital and factory resources being deployed to support third and fourth quarter business expansion in 2005. We are budgeting second quarter capital additions of approximately $145 million, primarily in key growth areas associated with the strategic initiatives we put in place in 2004.

     Our profitability is dependent upon the utilization of our capacity, product mix and the average selling price of our services. Because a substantial portion of our costs at our factories is fixed, relatively minor increases or decreases in capacity utilization rates can have a significant effect on our profitability. Prices for packaging and test services have declined over time. Historically, we have been able to partially offset the effect of price declines by successfully developing and marketing new packages, by negotiating lower prices with our material vendors, and by driving engineering and technological changes in our packaging and test processes which resulted in reduced manufacturing costs. We expect that average selling prices for our packaging and test services will continue to decline in the future. If our semiconductor package mix does not shift to new technologies with higher prices or we cannot reduce the cost of our packaging and test services to

25


Table of Contents

offset a decline in average selling prices, our future operating results will suffer. Supply shortages for critical components may occur in the future and in such an event, component prices could increase. If we continue to absorb component price increases, gross margin could be negatively impacted. In addition, the average price of gold has been increasing over the past few years. Although we have been able to partially offset the effect of gold price increases through price adjustments to customers and changes in our product designs, gold prices may continue to increase. To the extent that we are unable to offset these increases in the future, our gross margins could be negatively impacted.

Results of Operations

Overview

     The first quarter is generally a weak quarter for us due to a seasonal decline in orders from electronic and telecommunications customers following the holiday season and a shorter manufacturing calendar because of traditional holidays in several Asian countries where we have factories. Sales for the first quarter of 2005 were down 8% sequentially, as expected. Sales were also down 10% from the first quarter of 2004. First quarter results for 2004 were unusually high and first quarter 2005 is more in line with our seasonal expectations. The 2005 first quarter gross margin was lower than the first quarter of 2004 due to the impact of an increased fixed cost structure attributable to our 2004 capacity expansion and growth initiatives, seasonally lower revenues and erosion of average selling prices for our products. We will continue to see the effects of the increased cost structure on our margins until we realize the revenue growth we anticipate from these investments.

     Our first quarter results were significantly impacted by $50 million in charges related to the settlements of two mold compound litigation cases and the establishment of a loss provision for the remaining two cases. As part of a broader settlement agreement reached among Fujitsu, Cirrus Logic Inc. and Sumitomo Bakelite Co., we agreed to pay Fujitsu $40 million in consideration of a release of all claims. In addition, as part of a broader settlement reached among all parties in the Seagate case, and in consideration of a release of all claims, we agreed to pay Seagate $5 million. We have accrued an additional $5 million loss contingency in connection with the two remaining epoxy mold litigation cases. While the remaining cases are in the early stages of discovery, we believe these cases involve substantially smaller damage claims than the Fujitsu case. We will not realize any tax benefit from these charges as we currently establish a full valuation allowance for our net operating loss carry-forwards.

     The following table sets forth certain continuing operating data as a percentage of net revenues for the periods indicated:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
Net sales
    100.0 %     100.0 %
Gross profit
    10.4       24.1  
Operating income (loss)
    (18.2 )     10.3  
Income (loss) before income taxes and minority interest
    (28.5 )     2.7  
Net income (loss)
    (28.5 )     2.3  

Three Months Ended March 31, 2005 Compared to Three Months Ended March 31, 2004

     Net Sales — Packaging and test net sales decreased $47.2 million, or 10.2% to $417.5 million in the three months ended March 31, 2005 from $464.6 million in the three months ended March 31, 2004. This decrease in net sales was principally attributed to a decrease in overall unit volume (6.7%) and assembly price erosion (4.9%). The decrease in unit volume was driven by a 14.5% decrease in leadframe and a 7.4% decrease in laminate packages. Average selling prices in the three months ended March 31, 2005 declined approximately 4.9% as compared to average selling prices in the three months ended March 31, 2004. The decrease in sales is partially offset by the 5% increase in product line mix.

     Gross Profit. Gross profit decreased $68.5 million, or 61.2% to a gross profit of $43.4 million in the three months ended March 31, 2005 from $111.8 million in the three months ended March 31, 2004. Our cost of revenues principally consists of materials, labor and manufacturing overhead.

     Gross margin decreased to 10.4% in the three months ended March 31, 2005 from 24.1% in the three months ended

26


Table of Contents

March 31, 2004. The decrease in margin is principally a result of the following:

•   Decrease of average selling price erosion across our product lines decreased gross margin by approximately 4.4 percentage points.
 
•   Decreased unit volumes contributed approximately 6.7 percentage points to the decrease in gross margin.
 
•   Increased labor, depreciation, and other costs of goods sold costs contributed approximately 6.4 percentage points to the decrease in gross margin.
 
The unfavorable impacts on gross margin were partially offset by the following:
 
•   Material cost savings contributed approximately 0.4 percentage points to the increase in gross margin.
 
•   Product mix increased gross margin by approximately 2.3 percentage points.
 
•   Test sales of $5.4 million increase gross margins by 1.1 percentage points.

     Selling, General and Administrative Expenses — Selling, general and administrative expenses increased $6.3 million, or 12.1%, to $58.5 million or 14.0% of net sales, in the three months ended March 31, 2005 from $52.2 million, or 11.2% of net sales, in the three months ended March 31, 2004. Approximately $3.0 million of the increase in selling, general and administrative expenses is the result of the acquisitions made in the second half of 2004. The remaining $3.3 million increase is due to additional headcount, compensation costs and general business activity to support our overall business growth development in the amount of $6.2 million, partially offset by a decrease in legal costs related to the mold compound litigation. Legal costs associated with the mold compound litigation were $6.1 million for the first quarter of 2004 compared to $3.2 million for the first quarter of 2005.

     Research and Development — Research and development expenses decreased $0.1 million to $8.9 million, or 2.1% of net sales, in the three months ended March 31, 2005 from $9.0 million, or 1.9% of net sales, in the three months ended March 31, 2004. Our research and development efforts support our customers’ needs for smaller packages and increased functionality. We continue to invest our research and development resources to further the development of flipchip interconnection solutions, chip scale packages that are nearly the size of the semiconductor die, MEMS devices used in a variety of end markets including automotive, industrial and personal entertainment, our stacked chip packages that stack as many as three semiconductor dies in a single package, and System-in-Package technology, that uses both advanced packaging and traditional surface mount techniques to enable the combination of technologies in a single chip.

     Provision for Legal Settlements and Contingencies — For the three months ended March 31, 2005 we recorded a $50.0 million provision for legal settlements and contingencies related to the mold compound litigation, as discussed in the Overview above. For the three months ended March 31, 2004, we reached legal resolution with a customer regarding their claims against us related to mold compound and recorded a provision of $1.5 million associated with this settlement (see Part II, Item 1. — Legal Proceedings for further discussion).

     Other Expense — Other expense increased $7.7 million, or 22.1%, to $42.9 million in the three months ended March 31, 2005 from $35.2 million in the three months ended March 31, 2004. The net increase was primarily the result of an increase in interest expense of $7.2 million related to incurring additional debt in 2004 to finance our acquisitions. Foreign currency exchange loss increased $2.1 million due to the weakening of the US dollar against the various Asian currencies. In addition, for the three months ended March 31, 2004, other expense included $2.7 million of debt retirement expense associated with our refinancing in the first quarter of 2004.

     Income Taxes — For the three months ended March 31, 2005, we recorded income tax expense of $1.2 million reflecting an effective tax rate of 1.0%, as compared to an income tax expense of $1.4 million for the three months ended March 31, 2004, reflecting an effective tax rate of 11.3%. The tax expense for the three months ended March 31, 2005 and March 31, 2004 related to foreign withholding taxes and income taxes generated in our profitable foreign tax jurisdictions. During 2005, we continue to record a valuation allowances for substantially all of our deferred tax assets generated, including tax losses in the U.S. and certain foreign jurisdictions for which we do not anticipate a benefit. We will resume the recognition of deferred tax assets when we return to sustained profitability in our various tax jurisdictions. As of March 31, 2005, we had U.S. net

27


Table of Contents

operating loss carry-forwards totaling $330 million expiring through 2025. Additionally, as of March 31, 2005, we had $66 million of non-U.S. net operating losses available for carry-forward, expiring through 2010.

     The tax returns for open years in all jurisdictions in which we do business are subject to changes upon examination. During 2003, the Internal Revenue Service commenced an examination related to years 2000 and 2001. In February 2005, we verbally agreed to a settlement in principle with the IRS for these years. As a component of the settlement, we agreed to make certain income adjustments to our U.S. tax returns in the years 2000 through 2003 for local attribution of income resulting from significant inter-company transactions, including ownership and use of intellectual property, in various U.S. and foreign jurisdictions. These adjustments would effectively lower our U.S. net operating loss carry-forwards at December 31, 2004 by $52.7 million. This settlement agreement is not final until review and approval by the Congressional Joint Committee on Taxation, the timing of which is uncertain. We believe that we have estimated and provided adequate accruals for the additional taxes and interest expense that will result from these adjustments. Our estimated tax liability is subject to change as examinations of specific tax years are completed in the respective jurisdictions. We believe that any additional taxes or related interest over the amounts accrued will not have a material effect on our financial condition or results of operations, nor do we expect that examinations to be completed in the near term would have a material favorable impact. In addition, changes in the mix of income from our foreign subsidiaries, expiration of tax holidays and changes in tax laws or regulations could result in increased effective tax rates in the future.

Liquidity and Capital Resources

     Our ongoing primary cash needs are for debt service, equipment purchases and working capital. Our cash and cash equivalents balance as of March 31, 2005 was $286.8 million, and we had $29.7 million available under our $30.0 million senior secured credit facility. The amount available under our senior secured credit facility at March 31, 2005 was reduced by $0.3 million related to outstanding letters of credit. Cash flow from operations for the first quarter of 2005 was negative due to generating inadequate gross profit to cover operating expenses, as described in the Results from Operations above. In addition, we are obligated to payout $45.0 million in legal settlements in the second quarter of 2005. Even with the negative impact of these items, we believe that our existing cash balances, available credit lines, future cash flow from operations and available equipment lease financing will be sufficient to meet our debt service obligations, working capital requirements and litigation and settlement expenses for at least the next twelve months. However, during fiscal 2006 we will be required to make $238.9 million in principal payments primarily due to the maturity of our 5.75% Convertible Subordinated Notes in the amount of $233.0 million. These convertible notes will be classified as a current liability in our financial statements at the end of the second quarter of 2005. We are currently evaluating our alternatives to meet the principal payment obligation.

     We cannot assure you that additional financing will be available when we need it or, if available, that it will be available on satisfactory terms. In addition, the terms of the senior notes and senior subordinated notes significantly reduce our ability to incur additional debt. Failure to obtain any such required additional financing could have a material adverse effect on us. In May 2005 our liquidity and debt ratings were lowered reflecting heightened liquidity concerns and weak operating results.

     We are currently budgeting second quarter capital additions of approximately $145 million and project 2005 capital additions in the range of $250 million and $300 million. Ultimately, the amount of our 2005 capital additions will depend on several factors including, among others, the performance of our business, the need for additional capacity to service anticipated customer demand and the availability of suitable financing.

Cash Flows

     Net cash provided by (used in) operating, investing and financing activities for the three months ended March 31, 2005 and 2004 were as follows:

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
Operating activities
  $ (6,442 )   $ 97,338  
Investing activities
    (66,556 )     (137,397 )
Financing activities
    (11,816 )     71,752  

28


Table of Contents

     Cash flows from operating activities — Our cash flows from operating activities for the three months ended March 31, 2005 decreased $103.8 million to net cash used of ($6.4) million over the comparable prior year period. Our cash flows from operating activities decreased as a result of a decrease in net income of $130.0 million, offset by a decrease in our working capital and an increase in depreciation expense of $8.5 million over the comparable prior year period. Our working capital decreased primarily due to the accrual for legal settlements and contingencies of $50.0 million offset by a decrease in accounts payable of $10.1 million.

     Cash flows from investing activities — Our cash flows used in investing activities for the three months ended March 31, 2005 decreased by $70.8 million over the comparable prior year period, to $66.6 million, primarily due to a $77.1 million decrease in payments for property, plant and equipment from $143.9 million in the three months ended March 31, 2004 to $66.7 million in the three months ended March 31, 2005. During the three months ended March 31, 2004 payments for property, plant and equipment were significantly higher as we added production capacity and a new building in Taiwan in order to achieve an increase in sales. In addition, we paid $12.9 million during the three months ended March 31, 2004 to acquire the minority interest ownership in Amkor Iwate, bringing our ownership to 100%. These cash outflows were offset by cash proceeds from the collection of $18.6 million of notes receivable from Dongbu during the three months ended March 31, 2004.

     Cash flows from financing activities — Our net cash used in financing activities for the three months ended March 31, 2005 was $11.8 million, as compared to $71.8 million of cash provided by financing activities for the three months ended March 31, 2004. The decrease in cash flows from financing activities during the three months ended March 31, 2004 primarily related to our March 2004 issuance of $250.0 million of senior notes due 2011. The proceeds to us were $245.2 million, net of related discounts and debt issuance costs and were used to repay the balance outstanding under our senior secured term loan of $168.7 million. During the three months ended March 31, 2005 we repaid $11.7 million, net of borrowings related to our short and long-term debt obligations.

     We provide the following supplemental data to assist our investors and analysts in understanding our liquidity and capital resources. Free cash flow represents net cash provided by (used in) operating activities less investing activities related to the acquisition of property, plant and equipment. Free cash flow is not defined by generally accepted accounting principles (“GAAP”), and our definition of free cash flow may not be comparable to similar companies. We believe free cash flow provides our investors and analyst’s useful information to analyze our liquidity and capital resources.

                 
    March 31,     March 31,  
    2005     2004  
    (In thousands)  
Net cash (used in) provided by operating activities
  $ (6,442 )   $ 97,338  
Less: Payments for property, plant and equipment
    (66,712 )     (143,851 )
 
           
Free cash flow
  $ (73,154 )   $ (46,513 )
 
           

Debt and Related Covenants

     Debt decreased to $2,084.7 million at March 31, 2005, compared to $2,093.0 million at December 31, 2004. This decrease primarily reflects payments on our Japanese revolving credit facility and on other term debt.

     We were in compliance with all debt covenants contained in our loan agreements at March 31, 2005, and have met all debt payment obligations. Additional details about are debt is available in Note 9 accompanying the unaudited condensed consolidating financial statements included within Part I, Item 1 of this report.

Capital Additions

     Our first quarter capital additions were $47 million and we have budgeted second quarter capital additions of approximately $145 million. We expect that our full year 2005 capital additions will be in the range $250 million and $300 million. Ultimately, the amount of our 2005 capital additions will depend on several factors including, among others, the performance of our business, the need for additional capacity to service anticipated customer demand and the availability of suitable financing. The following table reconciles our activity related to property, plant and equipment payments as presented on the statement of cash flows to property, plant and equipment additions as reflected in the balance sheet:

29


Table of Contents

                 
    For the Three Months Ended  
    March 31,  
    2005     2004  
    (In thousands)  
Payments for property, plant and equipment
  $ 66,712     $ 143,851  
Increase (decrease) in property, plant and equipment in accounts payable and accrued expenses
    (19,681 )     26,987  
 
           
Property, plant and equipment additions
  $ 47,031     $ 170,838  
 
           

Off-Balance Sheet Arrangements

     We had no off-balance sheet guarantees or other off-balance sheet arrangements as of March 31, 2005.

Contingencies, Indemnifications and Guarantees

     Details about the company’s contingencies, indemnifications and guarantees are available in Note 12 accompanying the unaudited condensed consolidating financial statements included within Part I, Item 1 of this report.

Critical Accounting Policies

     Our critical accounting policies are disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2004. During the three months ended March 31, 2005, there have been no significant changes in our critical accounting policies.

New Accounting Pronouncements

     For information regarding recent accounting pronouncements, see Note 1 to the unaudited condensed consolidated financial statements within Part I, Item 1 of this report.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk Sensitivity

     We are exposed to market risks, primarily related to foreign currency and interest rate fluctuations. In the normal course of business, we employ established policies and procedures to manage the exposure to fluctuations in foreign currency values and changes in interest rates. Our use of derivatives instruments, including forward exchange contracts, has been insignificant throughout 2005 and 2004, and it is expected that our use of derivative instruments will continue to be minimal.

     Foreign Currency Risks

     Our primary exposures to foreign currency fluctuations are associated with transactions and related assets and liabilities denominated in Philippine pesos, Korean won, Japanese yen, Taiwanese dollar and Chinese renminbi. The objective in managing these foreign currency exposures is to minimize the risk through minimizing the level of activity and financial instruments denominated in those currencies. Our foreign currency financial instruments primarily consist of cash, trade receivables, investments, deferred taxes, trade payables and accrued expenses.

     For an entity with various financial instruments denominated in a foreign currency in a net asset position, an increase in the exchange rate would result in less net assets when converted to U.S. dollars. Conversely, for an entity with various financial instruments denominated in a foreign currency in a net liability position, a decrease in the exchange rate would result in more net liabilities when converted to U.S. dollars. Based on our portfolio of foreign currency based financial instruments at March 31, 2005 and December 31, 2004, a 20% increase (decrease) in the foreign currency to U.S. dollar spot exchange rate would result in the following foreign currency risk for our entities in a net asset (liability) position:

30


Table of Contents

                                         
    Chart of Foreign Currency Risk  
    Philippine     Korea     Taiwanese     Japanese     Chinese  
    Peso     Won     Dollar     Yen     Renminbi  
                    (In thousands)                  
As of March 31, 2005
  $ (2,752 )   $ 3,090     $ (12,710 )   $ 1,955     $ (1,151 )
As of December 31, 2004
  $ (2,266 )   $ 1,878     $ (2,740 )   $ 304     $ (1,980 )

     Interest Rate Risks

     Our company has interest rate risk with respect to our long-term debt. As of March 31, 2005, we had a total of $2,084.7 million of debt of which 84.4% was fixed rate debt and 15.6% was variable rate debt. Our variable rate debt principally consists of short-term borrowings and amounts outstanding under our $30.0 million revolving line of credit; of which no amounts were drawn as of March 31, 2005, but which had been reduced by $0.3 million related to outstanding letters of credit at that date. The fixed rate debt consists of senior notes, senior subordinated notes, convertible subordinated notes and foreign debt. As of December 31, 2004, we had a total of $2,093.0 million of debt of which 84.2% was fixed rate debt and 15.8% was variable rate debt. Changes in interest rates have different impacts on our fixed and variable rate portions of our debt portfolio. A change in interest rates on the fixed portion of the debt portfolio impacts the fair value of the instrument but has no impact on interest incurred or cash flows. A change in interest rates on the variable portion of the debt portfolio impacts the interest incurred and cash flows but does not impact the fair value of the instrument. The fair value of the convertible subordinated notes is also impacted by the market price of our common stock.

     The table below presents the average interest rates, maturities and fair value of our fixed and variable rate debt as of March 31, 2005.

                                                                 
    March 31, 2005                        
                    (In thousands)                                     Fair  
    2005     2006     2007     2008     2009     Thereafter     Total     Value  
Long-term debt:
                                                               
Fixed rate debt
  $ 24,706     $ 238,024     $ 149,663     $ 472,354     $ 200,627     $ 674,091     $ 1,759,465     $ 1,579,036  
Average interest rate
    5.2 %     5.7 %     5.0 %     9.2 %     10.5 %     7.5 %     7.8 %        
Variable rate debt
  $ 17,541     $ 2,151     $ 1,420     $ 1,193     $ 1,229     $ 301,657     $ 325,191     $ 340,191  
Average interest rate
    1.0 %     3.4 %     3.8 %     4.1 %     4.1 %     7.9 %     7.4 %        

     Equity Price Risks

     Our outstanding 5.75% convertible subordinated notes due 2006 and 5% convertible subordinated notes due 2007 are convertible into common stock at $35.00 per share and $57.34 per share, respectively. We currently intend to repay our remaining convertible subordinated notes upon maturity, unless converted or refinanced. If investors were to decide to convert their notes to common stock, our future earnings would benefit from a reduction in interest expense and our common stock outstanding would be increased. If we paid a premium to induce such conversion, our earnings would include an additional charge.

     Further, the trading price of our common stock has been and is likely to continue to be highly volatile and could be subject to wide fluctuations. Such fluctuations could impact our decision or ability to utilize the equity markets as a potential source of our funding needs in the future.

Item 4. Controls and Procedures

Restatement of Previously Issued Financial Statements

     We are filing this amendment on Form 10-Q/A to our Quarterly Report on Form 10-Q to restate our condensed consolidated financial statements for the three months ended March 31, 2005. In connection with finalizing the restatement of our previously filed financial statements for each of the three years in the period ended December 31, 2004, as included in our amended Annual Report on Form 10-K/A filed on June 6, 2005, we have revised the amount of unpaid capital expenditures utilized in preparing our condensed consolidated statement of cash flows for the three months ended March 31, 2005 that was included in our Quarterly Report on Form 10-Q filed on May 16, 2005. In conjunction with the restatement of

31


Table of Contents

our Annual Report, as described above, we restated our condensed consolidated financial statements included in our Quarterly Reports on Form 10-Q for the quarters ended March 31, June 30, and September 30 of 2004. We filed amendments on Form 10-Q/A to these Quarterly Reports on June 6, 2005.

Disclosure Controls and Procedures

     Amkor maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure based on the definition of “disclosure controls and procedures” in Rule 13a-15(e) and 15d-15(e) promulgated under the Exchange Act. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply judgment in evaluating our controls and procedures. Based on this evaluation and because of the material weakness described below, the principal executive officer and principal financial officer have concluded that Amkor’s disclosure controls and procedures were not effective as of March 31, 2005.

     Management, under the supervision and with the participation of our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of the design and operation of Amkor’s disclosure controls and procedures as of the end of the period covered by this report. Management has concluded that as of March 31, 2005, Amkor did not maintain effective controls over the preparation and review of our condensed consolidated statement of cash flows. Specifically, Amkor did not maintain effective controls to appropriately exclude from capital expenditures reported in the condensed consolidated statement of cash flows, capital expenditures that were unpaid and included in accounts payable or accrued expenses at the end of the reporting period. Thus capital expenditures were reported in the condensed consolidated statement of cash flows on an accrual basis rather than on a cash basis. This error resulted in a misstatement of cash flows from investing and operating activities. This control deficiency resulted in the restatement of the Company’s consolidated financial statements for the years ended December 31, 2004, 2003 and 2002 and for the interim periods in 2004 and 2003 and the first quarter of March 31, 2005. Further, if not remediated, this control deficiency could result in a misstatement of the consolidated statement of cash flows that would result in a material misstatement to annual or interim financial statements that would not be prevented or detected. Accordingly, management has determined this control deficiency constitutes a material weakness. As a result, Amkor’s management has restated its report, included in its amended Annual Report on Form 10-K/A for the Company’s fiscal year ended December 31, 2004 filed on June 6, 2005, on management’s assessment of the effectiveness of Amkor’s internal control over financial reporting and has disclosed that Amkor’s internal control over financial reporting was not effective as of December 31, 2004.

Changes in Internal Control Over Financial Reporting.

     During the most recently completed fiscal quarter there were no changes in our internal controls, over financial reporting that occurred during the last fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We are implementing a new Enterprise Resource Planning (“ERP”) system at certain locations, and in that process, we expect that there could be future changes at these locations that will materially affect our internal control over financial reporting.

     In an effort to remediate the material weakness in Amkor’s internal control over financial reporting described above, management has implemented a process to identify the amount of unpaid capital expenditures at the end of the reporting period to ensure capital expenditures are properly reflected in the condensed consolidated statement of cash flows in accordance with SFAS 95. Accordingly, management believes this process will remediate the material weakness discussed above.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

     We are currently a party to various legal proceedings, including those noted below. If an unfavorable ruling were to occur, there exists the possibility of a material adverse impact on our net results in the period in which the ruling occurs. The estimate of the potential impact from the following legal proceedings on our financial position or overall results of operations could change in the future. Attorney fees related to legal matters are expensed as incurred.

Epoxy Mold Compound Litigation

32


Table of Contents

    We have become party to an increased number of litigation matters relative to our historic levels. Much of our recent increase in litigation relates to an allegedly defective epoxy mold compound, formerly used in some of our packaging services, which is alleged to be responsible for certain semiconductor chip failures. In the case of each of the pending matters, we believe we have meritorious defenses, as well as valid third-party claims against Sumitomo Bakelite Co., Ltd. (“Sumitomo Bakelite”), the manufacturer of the challenged epoxy product, should the epoxy mold compound be found to be defective. We cannot be certain, however, that we will be able to recover any amount from Sumitomo Bakelite if we are held liable in these matters, or that any adverse result would not have a material impact upon us. Moreover, other customers of ours have made inquiries about the epoxy mold compound, which was widely used in the semiconductor industry, and no assurance can be given that claims similar to those already asserted will not be made against us by other customers in the future.

     Fujitsu Limited v. Cirrus Logic, Inc., et al.

     On April 16, 2002, we were served with a third-party complaint in an action entitled Fujitsu Limited v. Cirrus Logic, Inc., in the United States District Court for the Northern District of California, San Jose Division. Subsequently, substantially the same case was filed in the Superior Court of California, Santa Clara County, and the United States District Court case was stayed. In this action, Fujitsu Limited (“Fujitsu”) alleged that semiconductor devices it purchased from Cirrus Logic, Inc. (“Cirrus Logic”) were defective in that a certain epoxy mold compound manufactured by Sumitomo Bakelite and used by Amkor in the manufacture of the chip causes a short circuit which renders Fujitsu disk drive products inoperable. Cirrus Logic, in response, denied the allegations of the complaint, counterclaimed against Fujitsu for unpaid invoices, and filed its third-party complaint against us alleging that any liability for chip defects should be assigned to us because we assembled the subject semiconductor devices. We filed a cross-complaint against Sumitomo Bakelite asserting claims for breach of warranties and indemnification.

     On April 18 and 19, 2005, we participated in a private mediation with all parties involved. As a result of the mediation, on April 28, 2005 an agreement was reached among Fujitsu, Cirrus Logic, Sumitomo Bakelite and ourselves to settle this litigation; the parties entered the agreement into the record in Superior Court We have agreed to pay $40 million to Fujitsu in consideration of a release from and dismissal of all claims related to this litigation. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005. The $40 million is expected to be paid during the second quarter of fiscal 2005.

     Seagate Technology LLC v. Atmel Corporation, et al.

     In March 2003, we were served with a cross-complaint in an action between Seagate Technology LLC and Seagate Technology International (“Seagate”) and Atmel Corporation and Atmel Sarl (“Atmel”) in the Superior Court of California, Santa Clara County. Atmel’s cross-complaint seeks indemnification from us for any damages incurred from the claims by Seagate involving the allegedly defective epoxy mold compound manufactured by Sumitomo Bakelite. We answered Atmel’s cross-complaint, denying all liability, and filed a cross-complaint against Sumitomo Bakelite. Atmel later amended its cross-complaint to include claims for negligence and negligent misrepresentation against us and added ChipPAC Inc. (“ChipPAC”) and Sumitomo Bakelite as cross-defendants. ChipPAC filed a cross-complaint against Sumitomo Bakelite and us.

     On April 14, 2005 an agreement was reached among Seagate, Atmel, ChipPAC, Sumitomo Bakelite and ourselves to settle this litigation. We have agreed to pay $5 million to Seagate in consideration of a release from and dismissal of all claims related to this litigation. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005. The $5 million is expected to be paid during the second quarter of fiscal 2005.

     Maxtor Corporation v. Koninklijke Philips Electronics N.V., et al.

     In April 2003, we were served with a cross-complaint in an action between Maxtor Corporation (“Maxtor”) and Koninklijke Philips Electronics (“Philips”) in the Superior Court of California, Santa Clara County. Philips’ cross-complaint sought indemnification from us for any damages incurred from the claims by Maxtor involving the allegedly defective epoxy mold compound manufactured by Sumitomo Bakelite. Philips subsequently filed a cross-complaint directly against Sumitomo Bakelite, alleging, among other things, that Sumitomo Bakelite breached its contractual obligations to both us and Philips by supplying a defective mold compound resulting in the failure of certain Philips semiconductor devices. We denied all liability in this matter and also asserted a cross-complaint against Sumitomo Bakelite. Sumitomo Bakelite denied any liability. Maxtor and

33


Table of Contents

Philips reached a settlement of Maxtor’s claims against Philips on or about April 28, 2004 in which, reportedly, Philips agreed to pay Maxtor $24.8 million. On October 15, 2004, we and Sumitomo Bakelite reached a settlement agreement whereby Sumitomo Bakelite agreed to indemnify us for any damages awarded to Philips in excess of $3.5 million. In exchange, we dismissed our cross-claims against Sumitomo Bakelite. Trial of this matter before a jury began on October 18, 2004 and closing arguments were heard on November 29, 2004. On December 1, 2004, the Court and the jury rendered verdicts in our favor related to all of Philips’ claims against us. By those verdicts, we were exonerated of all alleged liability. The jury’s verdict further determined Sumitomo Bakelite’s share of liability to be 57% and Philips’ share to be 43%. Philips has agreed not to appeal the judgment in our favor in return for our agreement not to seek costs of suit from Philips. In January 2005, Sumitomo Bakelite appealed the judgment against it.

     We recorded a charge of $1.5 million related to the above matter during the three months ended March 31, 2004. However, in response to the December 1, 2004 verdict, we reversed this charge during the three months ended December 31, 2004.

Pending Epoxy Mold Litigation

     While the ultimate outcome is uncertain, as a result of the previously discussed epoxy mold compound litigation settlements, we have established a $5 million loss accrual related to the following two pending claims. This amount is reflected as part of the provision for legal settlements and contingencies in our Statement of Operations for the three months ended March 31, 2005.

     Maxim Integrated Products, Inc. v. Amkor Technology, Inc., et al.

     In August 2003, we were served with a complaint filed by Maxim Integrated Products, Inc. (“Maxim”) against us, Sumitomo Bakelite and Sumitomo Plastics America, Inc. (“Sumitomo Plastics”) in the Superior Court of California, Santa Clara County. The complaint seeks damages related to our use of Sumitomo Bakelite’s epoxy mold compound in assembling Maxim’s semiconductor packages. Written discovery is ongoing, with depositions and expert discovery to follow. The Court has set a trial date of April 24, 2006. We have denied all liability. We intend to defend ourselves vigorously, pursue our cross-claims against Sumitomo Bakelite and seek judgment in our favor.

     Fairchild Semiconductor Corporation v. Sumitomo Bakelite Singapore Pte. Ltd., et al.

     In September 2003, we were served with an amended complaint filed by Fairchild Semiconductor Corporation (“Fairchild”) against us, Sumitomo Bakelite, Sumitomo Plastics and Sumitomo Bakelite Singapore Pte. Ltd. in the Superior Court of California, Santa Clara County. The amended complaint seeks damages related to our use of Sumitomo Bakelite’s epoxy mold compound in assembling Fairchild’s semiconductor packages. Trial is currently scheduled to commence on November 7, 2005, and to last 15 court days. We have denied all liability. We intend to defend ourselves vigorously, pursue our cross-claims against Sumitomo Bakelite and seek judgment in our favor.

Other Litigation

     Amkor Technology, Inc. v. Motorola, Inc.

     In August 2002, we filed a complaint against Motorola, Inc. (“Motorola”) seeking declaratory judgment relating to a controversy between us and Motorola concerning: (i) the assignment by Citizen Watch Co., Ltd. (“Citizen”) to us of a Patent License Agreement dated January 25, 1996 between Motorola and Citizen (the “License Agreement”) and concurrent assignment by Citizen to us of Citizen’s interest in U.S. Patents 5,241,133 and 5,216,278 (the “‘133 and ‘278 patents”); and (ii) our obligation to make certain payments pursuant to an immunity agreement (the “Immunity Agreement”) dated June 30, 1993 between us and Motorola, pending in the Superior Court of the State of Delaware in and for New Castle County.

     We and Motorola resolved the controversy with respect to all issues relating to the Immunity Agreement, and all claims and counterclaims filed by the parties in the case relating to the Immunity Agreement were dismissed or otherwise disposed of without further litigation. The claims relating to the License Agreement and the ‘133 and ‘278 Patents remained pending.

     We and Motorola both filed motions for summary judgment on the remaining claims, and oral arguments were heard in September 2003. On October 6, 2003, the Superior Court of Delaware ruled in favor of us and issued an Opinion and Order granting our motion for summary judgment and denying Motorola’s motion for summary judgment. On October 22, 2003,

34


Table of Contents

Motorola filed an appeal in the Supreme Court of Delaware. In May 2004, the Supreme Court reversed the Superior Court’s decision, and remanded for further development of the factual record. A trial date has been set for October 17, 2005. We believe we will prevail on the merits at the Superior Court level. In addition, should Motorola prevail, we believe we will have recourse against Citizen.

     Citizen Watch Co. Ltd. v. Amkor Technology, Inc.

     We entered into an intellectual property assignment agreement (“IPAA”) with Citizen Watch Co., Ltd. (“Citizen”) with an effective date of March 28, 2002, pursuant to which Citizen assigned to us (i) its rights under a Patent License Agreement dated January 25, 1996 between Motorola and Citizen (the “License Agreement”) and (ii) Citizen’s interest in the ‘133 and ‘278 patents. The parties entered into the IPAA in conjunction with having entered into a Master Purchase Agreement under which we purchased substantially all of the assets of a division of Citizen in April 2002. Subsequent to that transaction, Motorola challenged the validity of Citizen’s assignment of its rights under the License Agreement to us, which resulted in our litigation with Motorola, Inc., which is described above (the “Motorola case”). Pending resolution of the Motorola case, and in accordance with the terms of the IPAA, we are withholding final payment of 1.4 billion yen ($13.0 million based on the spot exchange rate at March 31, 2005).

     In March 2004, Citizen submitted a Demand for Arbitration in the International Chamber of Commerce (“ICC”), claiming breach of our obligation to make the deferred payment of 1.4 billion yen. In May 2004, we filed our Answer to Request for Arbitration, Counterclaim and Request for Abeyance of Proceedings. In our Answer, we contend, among other things, that we do not have an obligation to make the deferred payment due to (i) our inability to perfect the rights assigned by Citizen under the License Agreement, and (ii) Citizen’s breach of its representations and warranties that it had all right and authority to assign its rights under the License Agreement to us.

     The arbitration hearing before the ICC on this matter was held in May 2005. A ruling by the ICC is expected by July 31, 2005.

     Alcatel Business Systems v. Amkor Technology, Inc., Anam Semiconductor, Inc.

     On November 5, 1999, we agreed to sell certain semiconductor parts to Alcatel Microelectronics, N.V. (“AME”), a subsidiary of Alcatel S.A. The parts were manufactured for us by Anam Semiconductor, Inc. (“ASI”) and delivered to AME. AME transferred the parts to another Alcatel subsidiary, Alcatel Business Systems (“ABS”), which incorporated the parts into cellular phone products. In early 2001, a dispute arose as to whether the parts sold by us were defective. On March 18, 2002, ABS and its insurer filed suit against us and ASI in the Paris Commercial Court of France, claiming damages of approximately 50.4 million Euros (approximately $65.1 million based on the spot exchange rate at March 31, 2005). We have denied all liability and intend to vigorously defend ourselves and have not established a loss accrual associated with this claim. Additionally, we have entered into a written agreement with ASI whereby ASI has agreed to indemnify us fully against any and all loss related to the claims of AME, ABS and ABS’ insurer. The Paris Commercial Court commenced a special proceeding before a technical expert to report on the facts of the dispute. The report of the court-appointed expert was put forth on December 31, 2003. The report does not specifically allocate liability to any particular party. On May 18, 2004, the Paris Commercial Court of France declared that it did not have jurisdiction over the matter. The Court of Appeal of Paris heard the appeal regarding jurisdiction during October 2004, confirmed the first tier ruling and dismissed the appeal. A motion was recently filed by ABS and its insurer before the French Supreme Court to challenge the lack of jurisdiction ruling.

     In response to the French lawsuit, on May 22, 2002, we filed a petition to compel arbitration in the United States District Court for the Eastern District of Pennsylvania (the “Court”) against ABS, AME and ABS’ insurer, claiming that the dispute is subject to the arbitration clause of the November 5, 1999 agreement between us and AME. ABS and ABS’ insurer have refused to arbitrate and continue to challenge the lack of jurisdiction ruling.

     Amkor Technology, Inc. v. Carsem (M) Sdn Bhd, Carsem Semiconductor Sdn Bhd, and Carsem Inc.

     In November 2003, we filed complaints against Carsem (M) Sdn Bhd, Carsem Semiconductor Sdn Bhd, and Carsem Inc. (collectively “Carsem”) with the International Trade Commission (“ITC”) in Washington, D.C. and subsequently in the Northern District of California. The complaints allege infringement of our United States Patent Nos. 6,433,277, 6,455,356, and 6,630,728 (collectively the “Amkor Patents”). We allege that by making, using, selling, offering for sale, or importing into the U.S. the Carsem Dual and Quad Flat No-Lead Package, Carsem has infringed on one or more of our

35


Table of Contents

MicroLeadFrame® packaging technology claims in the Amkor Patents. The District Court action had been stayed pending resolution of the ITC case. The ITC Administrative Law Judge conducted an evidentiary hearing during July and August of 2004 in Washington D.C. and issued an initial determination that Carsem infringed some of our patent claims relating to our MicroLeadFrame® package technology, that some of our 21 asserted patent claims are valid, and that all of our asserted patent claims are enforceable. However, the judge did not find a statutory violation of the Tariff Act. We filed a petition in November 2004 to have the judge’s ruling reviewed by the full International Trade Commission. The Commission as ordered a new claims construction related to various disputed claim terms and has remanded the case to the Administrative Law Judge for further proceedings. The Commission has set a new date of November 21, 2005 for completion of the investigation. The District court action remains stayed pending completion of the ITC investigation.

     Other Matters

     In June 2004, the Securities and Exchange Commission informed us that it was conducting an informal inquiry into certain trading in Amkor securities. The focus of the inquiry appears to be activities during the first half of 2004. We have cooperated with the inquiry by voluntarily producing documents to the Commission and providing testimony. The Commission staff has not informed us of any conclusions of wrongdoing by any person or entity.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

     None.

Item 3. Defaults Upon Senior Securities

     None.

Item 4. Submission of Matters to a Vote of Security Holders

     None.

Item 5. Other Information

     None.

Item 6. Exhibits

     The following exhibits are filed as part of this report:

     
Exhibit    
Number   Description of Exhibit
10.1
  Supplemental Indenture, dated as of January 5, 2005, among Amkor Technology, Inc. (“Amkor”), Amkor International Holdings, LLC (“AIH”), P-Four, LLC (“P-Four”), Amkor Technology Limited (“ATL”), Amkor/Anam Pilipinas, L.L.C. (“AAP”) and U.S. Bank National Association (“U.S. Bank”), as Trustee, to Indenture, dated as of May 13, 1999, among Amkor and U.S. Bank (as successor to State Street Bank and Trust Company), regarding Amkor’s 10 1/2% Senior Subordinated Notes due 2009. (1)
10.2
  Supplemental Indenture, dated as of January 5, 2005, among Amkor, AIH, P-Four, ATL, AAP and U.S. Bank, as Trustee, to Indenture, dated as of February 20, 2001, among Amkor and U.S. Bank (as successor to State Street Bank and Trust Company), regarding Amkor’s 9 1/4% Senior Notes due 2008. (1)
10.3
  Supplemental Indenture, dated as of January 5, 2005, among Amkor, AIH, P-Four, ATL, AAP and U.S. Bank, as Trustee, to Indenture, dated as of May 8, 2003, among Amkor and U.S. Bank, regarding Amkor’s 7.75% Senior Notes due 2013. (1)
10.4
  Supplemental Indenture, dated as of January 5, 2005, among Amkor, AIH, P-Four, ATL, AAP and Wells Fargo Bank, N.A., as Trustee, to Indenture, dated as of March 12, 2004,

36


Table of Contents

     
Exhibit    
Number   Description of Exhibit
  among Amkor and Wells Fargo Bank, N.A., regarding Amkor’s 7 1/8% Senior Notes due 2011. (1)
12.1
  Computation of Ratio of Earnings to Fixed Charges
31.1
  Certification of James J. Kim, Chief Executive Officer of Amkor Technology, Inc., Pursuant to Rule 13a — 14(a) under the Securities Exchange Act of 1934.
31.2
  Certification of Kenneth T. Joyce, Chief Financial Officer of Amkor Technology, Inc., Pursuant to Rule 13a — 14(a) under the Securities Exchange Act of 1934.
32
  Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(1)   Incorporated by reference to the Company’s current report on Form 8-K dated January 5, 2005 (filed as of January 10, 2005; SEC File Number 000-29472).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this amended report to be signed on its behalf by the undersigned thereto duly authorized.

AMKOR TECHNOLOGY, INC.

         
     
  By:   /s/ KENNETH T. JOYCE    
    Kenneth T. Joyce   
    Chief Financial Officer
(Principal Financial, Chief Accounting Officer and Duly Authorized Officer) 
 
 

Date: June 6, 2005

37